hg_192140.1

Basic information about the TSS

---

TSS ID: hg_192140.1 Species: human Chr: chr22		Start: 37560215 End: 37560296 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000430687.1 ENST00000249014.5 Distance: 184 GeneID: 11135 HGNC/MGI_ID: HGNC:17014 UniProt_ID: B0QYC8 Q00587

Gene_name: CDC42 effector protein 1 Gene_symbol: CDC42EP1 Gene_synonyms: Borg5 CEP1 MSE55 Gene_source: HGNC:17014

TATA-Box annotation

---

Distance to TSS:	-224
Nearest PromoterID:	NM_152243
Entrez ID:	11135
Nearest Unigene:	Hs.225356
Nearest Refseq:	NM_152243
Nearest Ensembl:	ENSG00000128283
Gene Name:	CDC42 effector protein 1
Gene Alias:	BORG5|CEP1|MSE55
Gene Description:	CDC42 effector protein 1
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.756219
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDC42EP1 p2@CDC42EP1 p3@CDC42EP1 p4@CDC42EP1 p5@CDC42EP1 p6@CDC42EP1 p7@CDC42EP1 p8@CDC42EP1 p9@CDC42EP1
Sample		p1@CDC42EP1	p2@CDC42EP1	p3@CDC42EP1	p4@CDC42EP1	p5@CDC42EP1	p6@CDC42EP1	p7@CDC42EP1	p8@CDC42EP1	p9@CDC42EP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	72.27	3.90	1.75	0.39	0.39	1.36	1.56	1.95	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	73.85	2.83	1.42	1.01	0.20	1.01	1.42	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	67.71	4.05	2.12	0.77	0.96	0.96	1.35	1.35	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	86.07	2.08	2.08	0.62	0.83	0.83	1.87	1.04	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	87.96	3.60	1.12	0.67	1.12	0.67	1.12	2.02	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	75.20	4.26	2.13	0.39	0.97	1.94	1.74	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	124.41	7.41	3.27	1.09	1.96	1.96	3.49	1.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	129.59	5.81	2.91	0.48	1.70	2.42	4.12	1.94	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	138.49	5.13	2.99	1.50	1.50	1.71	2.14	1.92	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	271.27	6.96	6.96	0.58	5.22	4.06	1.74	5.80	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	263.16	8.89	4.85	2.02	1.62	2.83	4.04	3.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	271.98	7.72	6.50	0.41	1.63	2.03	3.25	3.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	171.67	18.86	3.87	5.80	2.58	0.48	2.10	2.10	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	158.62	10.67	4.06	6.47	1.35	2.10	2.41	2.10	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	141.61	14.27	2.42	5.93	1.76	1.54	0.88	1.76	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	146.37	13.58	3.27	6.04	1.51	0.75	1.76	2.26	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	134.54	9.83	3.93	4.15	0.87	1.75	1.31	2.62	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	161.13	8.86	4.64	5.91	1.69	0.42	2.95	1.69	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	123.16	8.00	3.73	5.86	2.67	1.60	3.20	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	159.92	14.44	2.26	5.57	2.56	1.50	2.11	1.50	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	163.32	9.89	2.14	6.95	1.47	1.87	2.41	2.00	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	188.16	11.91	5.35	5.52	1.73	2.59	3.45	3.63	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	154.07	11.76	4.27	5.43	1.94	1.42	3.49	2.71	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	160.40	13.10	4.13	6.79	3.40	3.40	2.43	2.43	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	218.00	12.90	4.39	8.26	1.81	1.29	0.77	2.84	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	204.47	9.18	3.48	5.70	3.80	2.53	2.85	3.17	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	188.46	10.44	4.95	2.20	2.75	3.30	0.55	2.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	264.28	14.15	6.60	9.19	2.36	2.59	2.59	4.24	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	197.87	12.28	5.01	5.17	2.26	1.94	2.91	1.62	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	211.73	14.66	5.61	5.79	2.17	1.99	3.62	3.44	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	230.91	12.98	4.40	5.86	2.93	2.09	3.56	2.72	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	243.25	12.70	3.71	5.47	2.34	3.13	1.95	2.34	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	216.94	12.66	4.85	4.85	2.53	1.90	3.59	3.17	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	127.17	5.77	4.62	4.62	3.30	4.12	3.79	4.78	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	230.37	13.46	5.98	6.92	3.74	1.50	2.80	3.18	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	232.82	13.22	4.41	5.94	3.07	1.72	1.53	3.83	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	175.97	11.24	4.29	6.13	2.04	2.66	1.43	3.07	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	159.17	13.90	6.85	4.43	1.41	2.62	1.81	3.43	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	188.26	7.83	4.05	7.29	1.35	1.62	3.51	2.16	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	119.79	10.32	2.16	5.76	1.20	1.20	1.20	3.12	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	130.10	7.29	2.59	4.47	0.94	1.88	1.41	1.88	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	85.49	7.17	3.37	2.64	1.76	1.90	2.20	2.64	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	121.26	11.39	2.95	6.54	0.63	0.21	1.69	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	117.13	10.49	2.10	6.82	1.22	2.62	0.70	1.22	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	109.22	11.64	1.41	5.42	1.41	1.61	0.80	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	87.24	9.77	1.63	4.65	0.93	1.40	1.40	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	104.12	9.84	1.68	5.04	0.96	1.44	0.72	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	80.47	6.86	1.79	5.07	0.60	0.30	0.30	0.89	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	110.11	12.69	2.15	3.11	1.68	1.91	0.24	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	93.42	7.48	2.02	5.86	0.40	1.82	0.81	1.01	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	92.23	9.02	2.25	2.05	0.20	1.02	3.07	1.84	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	136.76	12.01	2.00	3.78	1.33	1.56	2.67	2.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	13.99	0.00	13.99	0.00	13.99	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	125.97	11.71	1.06	1.42	1.77	2.13	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	124.93	15.58	1.99	2.98	0.99	0.99	1.66	2.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	0.84	5.87	0.00	1.68	3.36	3.36	6.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	50.06	5.51	1.38	1.38	0.46	1.38	3.21	4.13	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	105.66	12.64	1.94	1.30	1.94	1.30	3.24	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	132.96	12.85	1.28	2.89	0.64	0.32	0.64	1.61	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	45.89	4.09	3.14	1.26	1.57	1.89	1.26	1.89	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	150.88	9.87	1.41	0.71	0.71	3.53	4.94	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	135.71	11.22	1.68	1.68	1.68	1.12	2.24	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	43.79	0.80	7.96	1.59	0.80	0.80	2.39	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	69.65	6.12	3.40	1.70	0.34	1.36	2.72	1.70	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	173.18	12.35	1.95	1.30	1.62	2.60	1.30	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	148.38	12.07	3.55	0.71	0.71	1.42	2.84	2.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	31.59	0.00	0.00	0.00	15.79	15.79	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	91.17	8.29	4.88	0.98	0.49	3.41	2.93	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	93.72	11.41	0.50	1.49	0.50	0.50	0.00	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	73.18	7.51	1.88	1.41	0.47	2.35	0.94	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.98	3.31	0.33	0.33	0.99	1.66	0.99	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	79.19	6.19	2.47	0.62	1.55	3.40	2.17	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	81.94	10.40	2.45	1.22	0.92	2.14	0.31	1.22	0.61
Adipocyte - breast, donor1	11376-118A8	134.15	5.70	3.17	1.58	3.48	2.38	2.22	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	77.97	4.49	6.10	2.25	1.44	4.01	3.85	2.09	0.00
Adipocyte - omental, donor1	11473-119C6	171.50	7.00	3.18	1.40	4.33	2.16	3.31	1.40	0.38
Adipocyte - omental, donor2	11474-119C7	94.18	3.74	3.74	2.24	2.99	2.99	3.74	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	102.49	2.34	4.69	5.36	3.35	2.68	3.35	2.68	0.00
Adipocyte - perirenal, donor1	11476-119C9	85.49	2.55	3.83	0.00	1.91	2.55	2.55	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	23.09	2.20	0.00	1.10	1.10	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	34.32	2.71	0.00	1.81	0.90	1.81	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.94	4.34	0.87	2.09	0.35	0.17	0.35	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	61.61	6.65	1.96	1.76	0.78	0.20	0.39	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	48.64	4.38	0.26	0.77	0.26	0.51	0.51	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	48.79	3.90	0.28	3.35	0.56	0.56	0.28	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	45.85	2.35	0.59	3.53	0.59	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.06	2.49	0.40	2.73	0.40	0.40	0.24	0.24	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	31.95	3.55	0.32	1.94	0.97	0.00	0.32	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	26.66	3.20	0.53	1.60	1.60	0.00	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	0.56	1.11	4.45	1.11	0.56	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	1.66	0.00	1.25	0.42	0.00	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	22.60	1.26	0.25	1.76	1.51	0.25	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.05	1.64	0.33	0.65	0.33	1.31	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.70	0.61	0.00	1.52	0.00	0.00	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	120.22	11.27	1.33	2.65	0.88	0.44	0.66	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	198.65	10.76	5.38	0.36	0.72	3.59	2.87	1.79	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	67.09	4.79	3.59	0.00	1.20	1.20	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	43.18	1.98	1.26	1.08	0.18	0.54	0.18	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	0.00	1.67	1.67	0.00	1.67	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	48.07	3.29	1.85	0.00	0.62	0.62	1.03	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	59.84	5.95	1.95	0.46	0.57	0.80	0.80	1.14	0.00
Anulus Pulposus Cell, donor2	11463-119B5	59.51	5.39	0.00	0.73	0.00	0.98	0.73	0.98	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.97	1.35	3.15	0.45	0.00	0.00	1.35	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.39	3.04	1.74	0.00	0.87	0.43	0.43	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	0.00	0.00	0.00	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.52	2.09	2.39	0.60	0.90	1.79	0.30	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	2.53	3.79	0.00	0.00	0.00	1.26	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	1.98	0.00	0.00	0.66	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.74	2.27	0.97	0.97	0.00	0.65	0.65	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	31.55	2.43	0.97	0.49	0.97	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	2.38	1.19	0.00	0.59	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	23.73	1.88	1.88	1.13	0.38	0.75	0.38	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	0.73	0.73	0.73	1.45	0.00	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	1.25	3.76	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	30.48	2.80	0.66	0.33	0.49	0.16	0.16	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	0.00	0.00	1.36	0.00	0.00	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.98	1.66	0.15	0.75	0.30	0.15	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.11	1.07	3.21	1.61	0.54	0.00	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.13	2.83	1.51	0.76	0.19	0.57	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	34.21	3.47	0.80	0.27	0.27	0.53	0.80	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	0.98	0.00	2.93	0.00	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.22	1.66	0.83	1.33	0.17	0.00	0.17	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	0.00	0.00	1.20	0.00	2.40	2.40	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.47	2.06	1.37	1.03	0.17	1.03	0.00	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	21.36	2.43	0.49	1.46	0.97	0.00	0.97	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.39	1.52	1.52	1.52	0.38	0.76	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	0.00	0.00	1.21	0.00	0.00	0.00	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.24	0.00	0.57	0.57	0.57	0.57	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.50	2.35	1.07	0.86	0.43	0.43	0.00	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	28.65	2.06	0.52	0.77	0.52	1.55	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.15	1.41	0.94	0.94	0.00	1.41	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	31.51	2.57	0.64	0.32	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	26.40	1.43	0.71	0.00	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	1.17	0.58	0.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.89	2.41	0.90	0.60	0.30	0.30	0.60	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.92	2.03	1.02	0.00	1.02	0.51	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.65	1.53	1.27	0.00	0.00	0.51	0.25	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	0.00	0.00	1.91	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.58	2.16	0.00	0.43	0.00	0.86	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.29	2.12	0.85	0.42	0.42	0.21	0.21	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	24.94	1.16	0.29	0.00	0.00	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	2.83	2.83	0.94	0.00	0.00	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.97	2.20	0.68	1.02	0.00	0.34	0.51	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	0.00	2.32	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	2.11	0.00	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.87	2.14	0.64	1.07	0.21	1.07	0.64	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.06	1.20	0.60	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	0.00	0.73	1.46	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	21.38	1.84	0.69	0.92	0.69	0.46	0.00	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	5.10	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.47	1.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.74	2.27	1.86	0.62	0.21	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.95	0.92	1.22	1.53	0.00	0.00	0.00	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	0.48	2.39	0.48	0.48	1.43	0.96	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.95	1.55	0.89	0.89	0.22	0.67	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	0.00	1.53	0.00	0.00	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.74	1.66	1.66	0.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.80	2.65	0.79	0.26	0.26	1.59	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.08	1.82	0.36	0.73	0.73	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	169.86	10.44	2.95	6.75	0.86	1.11	1.11	1.23	0.74
Astrocyte - cerebellum, donor2	11580-120F5	224.56	16.26	8.22	9.41	1.88	3.77	2.91	3.25	1.03
Astrocyte - cerebellum, donor3	11661-122F5	175.35	9.02	6.29	1.89	1.68	2.52	1.68	1.47	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	82.61	8.71	1.39	1.74	0.70	0.70	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	108.55	7.28	5.18	2.10	1.29	2.43	1.46	3.24	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	121.27	10.14	5.82	0.45	0.75	2.83	1.19	1.49	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	3.14	0.52	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	2.53	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	5.14	1.18	0.15	0.59	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	51.53	1.51	1.29	0.43	0.22	0.86	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	75.44	6.86	4.11	3.66	1.37	1.83	0.91	3.66	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	111.72	9.41	5.65	1.26	1.26	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	114.58	7.49	4.16	2.29	0.62	1.87	1.04	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	120.44	9.44	5.53	2.76	1.61	2.99	1.84	1.84	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	15.84	1.62	1.08	0.54	0.18	0.18	0.18	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	7.42	0.93	0.56	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	3.51	0.66	0.00	0.66	0.00	0.00	0.22	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1.90	0.38	0.00	0.38	0.38	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.57	1.97	0.00	0.99	0.00	0.33	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	2.75	0.43	0.00	0.29	0.00	0.00	0.14	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.02	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.21	0.95	0.24	0.24	0.00	0.00	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.67	0.00	0.00	0.33	0.17	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.31	0.83	0.28	0.83	0.00	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.98	0.74	0.00	0.25	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.78	0.39	0.00	0.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.42	0.36	0.18	0.18	0.00	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2.18	0.44	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	1.64	0.23	0.23	0.47	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	1.06	0.00	1.06	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	1.11	0.00	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.93	0.15	0.00	0.30	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.00	0.20	0.00	0.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.29	0.62	0.00	0.21	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.89	0.46	0.46	0.46	0.69	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.52	0.00	0.00	0.45	0.23	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.11	0.44	0.00	0.00	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.61	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.22	0.52	0.17	0.35	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.95	1.26	0.42	0.00	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.76	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.83	0.44	0.00	0.88	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.22	0.17	0.00	0.00	0.00	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.23	1.12	0.00	0.37	0.00	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.72	1.08	0.22	0.86	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.85	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.02	0.23	0.00	0.46	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	2.62	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.54	0.23	0.00	0.23	0.00	0.23	0.23	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	6.28	1.30	0.00	0.65	0.00	0.00	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.01	2.65	0.31	0.31	0.16	0.16	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	11.18	2.10	0.35	0.35	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	17.17	2.45	0.45	1.34	0.22	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.95	1.62	0.40	1.21	0.00	0.40	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	13.98	2.40	0.80	0.00	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.23	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.21	0.00	0.00	0.00	0.00	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1.66	0.00	0.00	0.00	0.00	0.28	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.25	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	1.15	0.00	0.23	0.23	1.38	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.71	0.96	0.00	0.00	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.75	0.55	0.27	0.27	0.00	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.80	0.60	0.00	0.00	0.00	0.60	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.36	1.44	0.48	0.24	0.24	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.14	2.05	0.45	0.00	0.00	0.00	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.35	1.09	0.22	0.00	0.22	0.43	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.21	0.53	0.00	0.00	0.00	0.00	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.63	1.64	0.23	0.00	0.23	0.23	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.94	1.51	0.00	0.00	0.00	0.00	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	1.45	0.00	0.00	0.00	0.00	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.33	1.07	0.00	0.00	0.00	0.00	0.27	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.44	0.44	0.00	0.00	0.00	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.38	1.82	0.00	0.00	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	1.49	0.00	0.00	0.00	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	0.72	0.36	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.63	1.44	0.29	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.90	0.94	0.47	0.47	0.00	0.24	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.56	1.27	0.63	0.00	0.00	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.23	1.85	0.00	0.31	0.31	0.00	0.62	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.98	2.56	0.64	0.00	0.00	0.00	0.00	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	0.76	0.38	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	2.36	0.00	0.00	0.00	0.39	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	2.41	0.00	0.00	0.00	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.99	2.10	0.00	0.00	0.00	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	3.01	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	122.46	1.83	1.83	3.66	0.00	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	73.62	4.94	1.48	0.99	0.49	0.99	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	92.08	6.31	1.16	1.79	0.21	0.42	0.11	0.53	0.32
Chondrocyte - de diff, donor1	11261-116G1	110.93	3.47	1.39	1.73	1.39	1.04	1.04	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	128.65	6.40	2.13	3.20	1.78	1.78	3.55	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	93.41	4.21	4.44	0.80	1.25	1.71	1.25	1.14	0.23
Chondrocyte - re diff, donor2	11339-117F7	112.80	2.69	0.00	6.27	0.00	3.58	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	82.90	4.85	1.21	2.43	0.40	0.81	2.02	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	93.30	8.26	1.15	0.92	0.69	0.46	0.34	0.80	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	102.82	8.98	4.49	2.14	1.50	0.86	2.57	2.99	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	101.86	8.23	3.72	3.19	1.33	1.42	1.15	0.97	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	81.16	5.87	1.83	1.28	0.83	0.92	0.64	0.46	1.74
Corneal Epithelial Cells, donor1	11526-119I5	138.33	6.59	1.10	0.88	0.44	1.32	0.88	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	94.42	2.28	2.28	0.00	0.00	4.55	2.28	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	97.91	6.14	3.83	1.79	1.02	1.79	0.77	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.65	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3.47	0.32	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	0.00	0.00	0.00	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.22	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	116.74	11.51	0.17	1.33	1.33	0.17	0.33	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	71.59	5.28	1.76	0.00	1.17	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	133.48	10.18	1.98	2.55	0.85	1.13	0.28	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	109.31	6.29	1.97	0.79	0.39	0.39	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	97.44	5.82	4.36	0.00	1.75	1.45	0.29	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	151.28	12.47	8.00	0.24	2.12	4.94	2.35	3.06	0.47
Endothelial Cells - Artery, donor3	11413-118E9	144.28	10.69	2.63	1.58	2.45	1.05	0.35	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	47.43	5.98	0.89	0.44	0.22	0.22	0.44	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	44.42	6.39	1.22	1.52	1.22	0.30	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	53.00	4.23	1.13	0.00	0.00	0.28	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	64.78	5.94	1.78	1.19	0.89	0.59	0.30	2.08	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	50.50	2.08	1.04	0.52	0.52	1.56	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	55.72	6.52	3.97	0.57	0.43	0.85	0.28	0.85	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	101.23	3.20	1.60	1.60	1.20	1.20	0.80	2.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	117.93	4.72	4.19	0.00	0.52	4.72	3.14	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	85.23	10.06	3.11	1.74	1.37	0.50	1.49	0.99	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.70	7.60	0.43	1.09	0.22	0.65	0.43	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	84.39	11.36	0.61	0.73	0.24	0.61	0.37	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	136.50	6.83	2.28	2.28	0.00	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	143.89	16.76	1.40	0.00	2.79	0.70	1.40	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	106.61	10.83	2.04	2.83	1.41	1.10	0.63	0.94	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	50.82	4.15	0.73	0.24	0.24	0.98	0.98	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	104.01	0.00	0.00	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	112.89	5.34	0.41	0.41	1.23	1.23	1.23	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	31.42	1.86	1.75	1.20	1.09	1.09	1.53	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	88.51	4.98	3.58	0.43	1.52	3.03	2.71	2.49	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	85.74	5.22	3.15	1.82	2.67	1.21	1.82	2.55	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.16	0.96	0.68	1.23	0.00	0.14	0.00	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.49	5.91	5.38	2.74	2.85	2.53	2.43	0.95	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.69	1.32	1.32	0.00	0.26	0.79	0.53	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	86.04	8.30	7.31	1.00	1.66	2.33	1.66	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	96.62	5.44	3.63	3.18	1.36	0.91	0.45	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	119.76	6.82	1.52	0.76	2.27	0.76	0.00	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	87.53	6.15	5.20	0.95	1.10	1.58	2.37	1.26	0.16
Fibroblast - Cardiac, donor4	11452-119A3	103.97	6.67	1.52	2.12	2.12	0.30	0.91	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	88.58	5.96	3.55	0.76	1.27	1.65	1.02	1.02	0.00
Fibroblast - Cardiac, donor6	11460-119B2	79.74	5.76	1.36	0.91	0.76	0.76	1.21	1.21	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	117.24	5.49	2.95	1.47	1.07	0.94	1.07	1.07	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	72.91	3.45	3.02	0.43	0.43	0.43	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	89.35	16.11	5.86	4.39	0.00	2.93	0.00	4.39	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	390.70	34.83	5.30	6.00	0.92	2.31	1.85	2.08	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	73.61	4.58	2.20	1.53	0.85	0.51	0.51	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	30.52	2.11	1.64	1.64	1.17	0.70	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	71.70	10.85	0.47	0.47	0.47	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	47.02	7.49	1.57	2.06	1.09	0.60	0.24	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	57.65	8.03	4.18	0.90	0.79	2.15	1.81	1.47	0.00
Fibroblast - Dermal, donor5	11454-119A5	64.37	6.45	3.49	1.22	0.70	1.40	0.70	1.57	0.00
Fibroblast - Dermal, donor6	11458-119A9	40.12	5.04	1.95	1.30	0.65	0.97	0.32	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	45.39	3.96	2.08	0.62	0.21	0.42	0.62	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	107.16	3.93	4.98	1.31	2.88	2.36	2.62	2.10	0.00
Fibroblast - Gingival, donor2	11318-117D4	59.57	8.04	4.22	1.71	0.79	1.84	1.71	1.58	0.00
Fibroblast - Gingival, donor3	11394-118C8	89.44	9.09	5.70	0.68	1.93	2.80	0.68	0.58	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	49.87	4.16	1.04	3.12	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	53.92	4.93	3.17	2.11	2.29	0.88	1.59	1.41	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	88.24	6.39	2.03	0.94	0.94	1.56	0.16	0.78	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	51.52	2.57	2.30	0.68	0.68	0.68	1.35	0.95	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	229.72	17.29	4.94	3.53	7.41	0.71	4.59	2.12	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	75.61	4.83	2.19	1.17	0.44	1.90	1.17	0.88	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	73.63	3.27	2.05	0.41	1.09	1.36	1.91	1.50	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	92.14	4.94	3.73	0.99	1.65	0.77	1.76	1.65	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.33	3.82	2.35	0.59	2.20	1.76	2.64	1.32	0.00
Fibroblast - Lung, donor1	11270-116H1	85.64	13.59	2.72	1.36	2.72	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	64.16	5.97	1.49	0.00	0.00	2.98	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	90.11	14.56	4.43	5.91	0.21	2.53	0.84	1.27	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	263.23	19.16	5.83	1.67	2.50	0.83	1.67	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	107.69	5.59	4.20	2.80	2.80	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	188.08	9.80	11.20	0.28	2.52	3.64	2.80	3.36	0.00
Fibroblast - Mammary, donor1	11540-120B1	211.51	24.76	2.44	3.65	0.81	0.81	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	175.75	0.00	3.99	3.99	0.00	11.98	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	113.17	17.87	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.24	6.98	0.00	0.78	0.19	0.00	0.19	1.16	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.16	13.20	4.55	0.61	1.37	2.73	1.06	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.64	6.43	0.92	0.00	0.61	0.31	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	59.15	2.29	1.91	0.38	0.38	0.38	0.76	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	72.36	5.13	1.62	0.81	0.81	1.89	1.89	2.70	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	53.58	6.49	0.81	2.09	0.35	0.46	0.58	1.16	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	70.63	5.97	1.33	0.77	0.44	0.33	0.55	0.22	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	168.04	12.39	2.84	0.61	0.81	2.64	0.20	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	93.55	5.35	4.68	3.34	0.00	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	52.19	3.95	1.19	0.79	0.40	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.86	1.59	1.59	0.40	0.20	0.79	0.40	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	81.35	3.55	1.60	1.24	0.53	0.71	0.36	1.07	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	75.09	3.94	2.76	3.94	0.39	0.39	0.59	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.92	1.20	0.90	0.00	0.00	0.30	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	65.85	4.21	2.05	1.51	1.73	1.30	0.86	0.54	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	46.82	2.28	1.52	0.76	0.25	1.01	0.76	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	106.49	3.45	2.63	2.79	1.48	0.82	0.49	1.80	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	47.72	3.41	0.60	1.20	0.80	0.00	1.00	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	111.91	5.02	4.52	3.52	1.41	1.81	2.21	1.31	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.31	1.21	2.12	0.60	1.21	0.60	0.00	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	98.75	6.38	2.57	1.16	1.24	0.99	0.99	1.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.40	3.93	3.42	2.56	0.68	2.56	1.37	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	46.64	1.97	1.64	1.97	0.66	0.99	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	89.69	5.01	3.62	2.88	1.70	1.38	2.02	1.38	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	95.30	6.92	2.53	0.67	1.01	1.35	1.01	0.84	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.93	1.41	7.84	1.25	1.25	3.14	2.67	5.96	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.03	0.87	2.61	0.00	0.87	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	97.77	2.95	0.69	1.04	1.04	0.35	0.69	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	117.89	1.82	2.60	1.04	1.30	0.26	0.78	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	105.78	3.07	2.04	0.51	2.56	0.26	0.77	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	3.06	0.77	1.53	0.00	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	3.19	0.64	2.55	0.64	2.55	1.28	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	5.42	1.71	0.29	0.00	0.29	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	19.85	3.86	1.38	0.28	3.03	0.28	0.83	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.75	2.28	0.68	0.68	2.51	0.46	0.68	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	11.10	1.78	0.20	0.20	1.19	0.00	0.00	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	15.07	3.44	0.79	0.26	3.70	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.77	2.28	0.98	1.30	2.28	0.00	0.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.52	0.88	0.88	0.88	0.88	0.88	0.00	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.95	2.54	1.13	1.27	0.42	0.42	0.00	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.39	2.96	0.86	1.48	0.62	0.62	0.25	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	14.51	0.81	2.15	0.81	0.81	0.27	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	77.81	10.28	4.96	1.61	3.35	1.36	1.49	1.36	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	67.55	10.94	5.12	1.94	1.80	2.08	0.97	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.76	6.10	3.46	1.63	2.64	1.83	2.24	1.83	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.81	4.79	2.28	2.97	0.68	0.46	1.37	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	44.35	7.22	3.86	2.62	1.62	1.62	0.62	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	58.36	11.37	3.06	2.40	1.75	0.22	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	40.78	5.61	1.77	2.07	2.07	0.30	0.00	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.74	2.07	2.38	1.27	1.11	1.11	0.79	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	36.19	3.35	1.12	0.67	1.34	0.22	0.89	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	45.77	4.64	2.82	3.83	1.21	0.60	1.01	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.86	2.71	2.21	1.36	0.85	0.85	0.51	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.47	4.79	2.22	1.95	2.39	0.71	0.98	0.80	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	106.24	9.47	3.85	4.99	4.06	1.98	0.31	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	77.70	6.49	2.39	6.15	2.22	1.20	1.02	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	36.74	4.20	2.32	1.66	1.55	0.89	0.44	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.60	3.00	1.75	1.41	0.67	0.58	0.58	0.58	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.12	3.47	0.41	1.63	0.82	0.20	0.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.99	6.19	1.86	2.06	1.44	1.03	0.62	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.93	5.88	1.73	3.80	1.15	0.81	0.69	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.86	4.67	1.67	2.33	1.50	0.83	0.83	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.87	4.63	3.97	3.53	1.54	1.32	0.88	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.05	4.30	2.95	3.57	1.23	0.86	0.74	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.01	3.40	2.11	2.76	0.81	0.16	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.24	3.53	2.57	2.89	0.32	0.64	0.32	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.60	4.26	1.90	3.03	1.42	0.57	0.66	1.42	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.50	5.38	1.42	2.21	0.79	0.79	0.95	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.75	4.26	1.52	2.13	1.82	0.91	0.91	2.43	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.78	3.66	2.40	2.20	0.84	0.84	0.63	0.84	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.93	2.85	0.88	2.20	0.66	0.44	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.97	2.81	1.40	1.40	0.00	0.28	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.02	2.22	0.56	1.76	1.30	0.56	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	30.22	2.67	1.60	1.07	1.07	1.34	0.80	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.57	2.60	1.84	2.60	0.61	0.92	0.31	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.53	3.24	1.94	1.42	0.91	0.52	0.65	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.92	1.63	1.36	1.08	0.81	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.14	4.06	2.21	0.92	0.74	0.55	0.18	1.29	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	49.35	4.82	2.63	1.97	0.66	0.88	1.32	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	6.94	1.98	1.98	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	56.46	4.22	2.90	2.11	1.06	1.06	0.66	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	50.44	3.63	2.02	2.22	1.41	0.81	0.40	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	134.96	13.47	3.30	4.57	1.02	0.25	0.25	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.36	2.39	0.60	1.19	0.40	0.60	0.20	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.63	2.16	1.39	0.62	0.31	0.31	0.31	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.77	2.05	0.61	2.45	0.00	0.00	0.00	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.51	0.63	0.00	0.63	0.31	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.24	1.70	0.28	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	4.95	0.00	2.47	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	21.27	2.32	0.77	0.00	0.00	0.00	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	0.00	3.21	0.00	3.21	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	0.00	0.00	0.00	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.74	0.65	1.30	0.33	0.98	0.98	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.24	0.41	2.06	0.00	0.41	0.41	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	19.85	0.84	0.28	0.00	0.56	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.59	0.98	1.31	0.00	0.00	0.98	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	2.52	0.00	0.00	0.00	0.00	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.27	1.59	0.00	0.64	0.64	0.00	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.72	1.36	1.02	0.00	0.00	1.02	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.90	2.86	2.29	0.57	0.00	1.15	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.45	2.07	1.18	0.59	0.00	0.00	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	23.72	0.00	1.69	0.00	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	28.58	1.24	0.83	0.41	1.24	0.83	1.66	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.41	1.15	1.15	0.23	0.23	0.92	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	22.30	1.54	0.77	0.77	0.77	0.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	30.97	1.30	0.33	0.65	1.30	0.65	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	0.00	0.67	0.00	0.00	1.34	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.07	2.70	1.54	0.39	0.39	1.54	1.16	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	77.03	1.71	2.74	0.00	1.71	1.37	2.40	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	2.48	7.45	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.94	3.77	0.00	0.00	0.94	0.00	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.83	2.41	1.21	0.00	0.00	2.41	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	42.73	1.53	1.02	0.51	2.54	0.00	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.53	1.99	0.80	0.80	0.80	0.40	0.00	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	39.96	2.96	1.97	0.49	0.49	0.49	0.49	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	3.54	2.36	0.00	0.00	2.36	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	1.75	3.50	0.58	1.75	0.58	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.50	0.00	3.51	0.00	1.76	0.88	0.44	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	0.00	3.39	0.00	0.00	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	2.39	0.00	0.00	0.00	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.78	0.00	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	52.50	7.99	0.00	0.00	2.28	0.00	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	125.16	6.65	9.56	2.49	0.83	2.49	3.33	3.74	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	150.68	13.49	4.50	7.87	5.62	1.12	2.25	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	58.36	4.12	1.59	1.27	0.63	0.95	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.08	2.92	0.42	0.00	0.00	0.84	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	78.91	3.60	4.41	3.13	0.35	1.86	1.16	2.20	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	78.16	3.38	5.23	3.04	1.01	2.36	1.01	1.69	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.98	3.64	3.64	2.28	0.68	0.68	0.46	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	72.47	2.08	4.04	3.39	1.20	2.51	1.31	2.40	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	71.78	4.51	3.22	2.36	0.21	2.58	1.29	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	58.77	1.72	3.44	2.15	0.22	0.86	0.43	1.94	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	47.70	3.86	2.62	2.62	0.87	1.00	0.62	1.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	41.34	2.40	1.54	2.40	0.51	1.03	0.17	1.20	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	44.53	1.92	0.96	2.24	0.96	1.60	0.32	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	90.10	8.39	5.60	0.56	2.24	2.80	1.12	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	147.15	11.25	9.09	0.00	2.16	2.60	0.87	3.03	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	2.64	7.93	0.00	0.00	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	217.28	13.76	2.47	2.12	0.35	1.06	0.71	0.35	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	175.82	11.62	2.91	3.63	0.73	3.63	3.63	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.57	3.67	1.57	0.52	0.70	1.57	0.35	1.05	0.35
Hepatocyte, donor1	11523-119I2	73.85	2.42	2.42	0.00	0.00	1.21	0.00	3.63	0.00
Hepatocyte, donor2	11603-120I1	226.24	6.46	9.70	0.00	4.31	1.08	1.08	4.31	0.00
Hepatocyte, donor3	11684-122I1	59.51	1.23	0.61	0.61	0.00	0.00	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	70.09	2.27	2.80	2.62	0.87	0.70	0.87	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.59	6.72	1.23	0.27	0.27	1.10	0.27	0.96	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	85.97	19.10	6.37	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	20.03	0.00	0.00	0.00	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	71.99	6.92	5.54	2.77	2.77	2.77	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	7.51	2.50	0.00	5.01	2.50	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	11.87	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	79.45	7.69	7.69	5.13	2.56	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	73.13	4.57	0.00	4.57	4.57	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	94.21	9.75	3.25	1.62	1.62	0.00	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	70.03	3.33	8.34	3.33	3.33	8.34	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	98.03	7.26	3.63	3.63	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	104.55	13.23	6.62	0.00	2.65	3.97	3.97	6.62	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	5.54	3.33	0.00	0.00	1.11	2.22	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	94.29	5.24	5.24	5.24	0.00	0.00	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	70.54	9.45	1.89	0.00	1.26	1.89	1.89	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	85.06	12.37	6.19	0.00	0.00	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	95.61	16.80	7.11	1.94	3.23	0.65	2.58	5.17	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	117.52	17.71	11.27	3.22	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	11.95	0.00	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	126.31	11.41	4.07	2.44	1.63	0.81	3.26	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	117.13	21.41	4.20	4.62	2.52	1.68	1.68	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	172.47	0.00	0.00	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	102.07	12.06	4.02	0.80	2.41	2.41	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	70.17	8.31	3.69	1.85	0.00	0.00	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	73.64	8.50	3.78	0.00	0.94	2.83	0.94	2.36	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	60.77	2.72	4.53	0.00	0.00	0.00	0.00	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	74.25	17.22	7.53	1.08	1.08	1.08	4.30	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	96.56	11.43	2.54	3.81	1.27	1.27	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	102.03	7.65	9.57	3.19	1.91	3.19	2.55	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	113.00	3.65	7.29	1.82	3.65	1.82	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	101.40	11.43	10.00	0.71	3.57	3.57	3.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	6.64	9.95	0.00	0.00	0.00	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	74.70	5.86	2.78	0.93	1.23	2.78	2.78	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	12.29	3.51	0.00	1.76	3.51	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	122.58	18.86	12.57	0.00	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	116.13	19.47	6.26	2.09	0.00	3.48	1.39	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	152.70	22.13	6.64	0.00	0.00	2.21	4.43	8.85	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	142.65	9.73	3.24	0.00	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	151.72	20.93	13.08	4.36	3.49	2.62	4.36	6.98	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	195.73	6.75	9.00	2.25	0.00	2.25	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	216.04	10.45	10.45	6.97	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	202.69	23.47	14.93	4.27	4.27	4.27	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	133.00	18.01	6.93	4.16	0.00	2.77	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	88.34	19.95	0.00	2.85	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	121.50	11.97	6.44	2.76	1.84	3.68	4.60	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	175.47	12.10	6.05	6.05	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	192.47	12.42	0.00	6.21	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	181.87	27.49	7.40	3.17	6.34	6.34	4.23	5.29	0.00
Keratinocyte - epidermal, donor1	11272-116H3	135.13	3.43	5.06	1.63	3.10	1.88	1.47	1.22	0.08
Keratinocyte - epidermal, donor2	11349-117G8	243.04	11.71	4.10	0.00	2.34	1.76	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	87.75	5.11	2.75	0.85	0.66	1.89	0.47	1.33	0.00
Keratinocyte - oral, donor1	11251-116E9	72.42	4.77	3.52	0.45	1.14	0.68	0.23	0.79	0.11
Keratocytes, donor1	11527-119I6	207.67	23.04	2.06	4.13	2.06	0.00	2.41	2.06	0.00
Keratocytes, donor2	11607-120I5	53.90	3.52	3.52	0.00	1.17	1.17	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	70.54	9.09	1.78	1.78	0.99	0.40	1.38	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	96.71	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	70.12	3.24	3.24	2.16	1.08	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	26.07	3.46	0.58	2.65	0.00	0.12	0.23	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	76.29	6.36	0.71	1.92	0.30	0.00	0.40	0.10	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	48.38	6.28	1.54	0.95	0.95	0.83	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	47.44	6.14	0.00	0.84	0.00	0.28	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.37	2.99	2.36	0.94	0.63	0.94	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	36.56	3.76	1.08	0.54	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.01	4.73	1.89	0.32	0.63	0.95	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	34.61	3.13	2.48	0.54	0.65	0.65	0.32	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.22	5.75	0.41	0.41	0.41	0.41	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	67.50	4.30	3.29	1.01	0.51	0.51	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	41.52	3.38	2.82	0.99	0.84	1.13	0.14	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.19	3.96	1.58	0.79	0.40	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	65.53	5.04	1.74	0.78	0.58	0.58	0.00	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	52.21	4.63	1.67	0.56	0.56	0.56	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	50.52	4.53	3.14	0.35	0.00	0.35	0.35	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	75.61	7.87	1.43	0.48	0.72	0.95	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	48.07	4.67	2.88	0.41	0.96	0.41	0.41	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	64.36	5.24	2.16	0.92	0.92	1.54	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	61.73	8.73	2.49	0.31	0.94	1.25	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	58.19	4.76	2.74	0.18	0.91	1.46	0.37	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	49.37	4.28	2.96	1.97	0.33	0.00	0.99	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	61.21	4.39	2.64	0.59	0.29	0.29	0.29	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	53.77	2.74	1.99	0.75	0.75	0.50	0.50	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	51.41	3.39	0.97	0.97	0.48	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	68.67	3.77	1.89	0.00	0.81	0.27	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	46.62	4.84	3.03	0.91	1.36	0.61	0.30	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.47	1.04	1.56	0.00	1.04	1.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	74.33	6.28	1.68	0.84	0.00	0.21	0.84	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	40.30	4.81	2.26	1.20	0.00	1.50	0.30	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	55.03	4.82	1.38	0.00	1.38	0.00	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	62.47	5.83	2.07	1.13	0.00	0.56	0.56	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	37.96	4.77	2.54	0.74	0.64	1.06	0.42	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	52.82	0.97	0.48	1.45	0.97	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	62.85	6.95	4.96	0.66	0.00	1.32	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	44.48	4.34	2.97	0.37	1.12	1.12	0.50	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.35	1.85	2.22	0.37	0.37	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	59.05	5.19	2.22	1.48	0.49	0.99	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	36.85	4.67	1.79	1.24	1.10	0.82	0.27	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	43.74	3.22	2.25	0.00	0.96	1.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	65.43	6.70	3.65	0.61	0.91	0.30	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.31	3.78	2.24	1.12	0.42	0.70	0.14	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.05	3.20	2.49	0.36	0.71	0.36	0.71	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	65.93	4.85	4.36	0.48	1.94	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.71	5.29	2.96	0.31	1.09	0.62	0.78	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	55.86	4.30	1.43	0.00	0.72	0.36	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	70.24	7.51	2.29	0.65	0.65	0.33	1.31	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	41.20	3.06	1.41	1.18	1.18	0.24	0.47	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	57.05	6.19	1.61	0.87	0.87	0.50	0.12	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	78.89	6.15	2.56	0.77	0.51	0.00	0.51	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	40.28	4.48	2.39	0.00	0.30	0.60	0.30	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	0.00	0.42	0.42	0.42	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	1.41	0.00	0.70	0.70	0.70	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	1.87	0.00	0.00	0.00	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	0.52	1.03	0.52	0.52	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	0.00	1.19	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.99	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.18	0.00	0.00	0.00	0.58	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	17.48	1.08	0.27	0.27	0.27	0.14	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	1.54	0.51	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.76	0.00	0.00	0.71	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	0.00	0.00	0.00	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	0.51	1.02	0.00	0.00	1.02	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	0.00	0.53	0.00	0.27	0.53	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.85	0.38	0.38	0.00	0.00	0.00	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	0.00	0.61	0.00	0.00	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	15.49	0.82	0.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.91	0.00	1.46	0.00	0.00	1.04	0.83	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.41	0.56	1.12	0.00	0.56	0.28	0.28	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	0.00	2.06	0.00	0.00	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	10.16	0.87	1.45	0.00	0.00	0.29	0.87	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.86	0.30	0.00	0.00	0.30	0.00	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	0.00	0.00	0.55	0.00	0.55	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	1.06	2.47	0.00	0.35	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.01	0.37	1.48	0.00	0.74	0.00	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	0.00	1.15	0.00	0.00	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	18.42	0.77	0.00	0.00	0.77	0.00	0.77	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.29	0.00	0.00	0.00	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.13	0.82	0.00	0.00	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	10.85	0.00	0.45	0.00	0.00	0.90	1.36	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	11.49	1.44	0.00	0.72	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	1.49	0.75	0.75	0.00	0.00	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.66	0.37	1.11	0.37	0.74	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.18	0.86	0.43	0.00	0.43	0.43	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.99	0.67	1.00	0.67	0.33	0.33	1.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	0.60	0.00	0.60	0.60	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	1.42	1.42	0.71	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	1.37	0.69	0.00	0.00	0.69	0.00	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	1.07	1.07	0.00	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	0.67	0.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.59	0.37	0.37	0.37	0.74	1.11	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	0.00	0.00	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	0.00	0.00	1.06	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.41	0.80	2.00	0.00	0.40	0.00	0.80	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	18.40	0.00	1.53	0.00	0.77	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.84	0.99	0.49	0.00	0.49	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	0.00	0.50	0.50	0.00	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	0.45	0.90	0.00	0.45	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	0.00	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.36	1.34	0.00	0.00	0.89	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	0.78	1.56	0.00	0.39	0.78	0.78	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.92	0.66	0.00	0.66	0.66	0.00	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	0.52	0.00	0.52	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	0.44	2.19	0.44	0.00	1.31	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.42	0.56	0.56	0.00	0.56	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	0.00	0.00	0.00	0.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.74	0.39	0.39	0.39	0.39	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	0.00	0.00	0.51	0.00	0.00	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	0.96	0.00	0.00	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	0.40	1.19	0.00	0.40	0.00	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	0.00	2.43	0.00	1.22	1.22	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	1.38	0.69	1.38	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.56	1.90	0.00	0.38	0.00	1.52	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.07	0.52	2.07	0.00	0.00	1.03	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.35	0.60	1.81	0.00	0.60	0.60	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.45	0.95	0.95	0.63	0.32	0.32	0.63	1.58	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.46	0.00	1.07	1.07	0.00	1.07	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.29	0.57	0.57	0.00	0.00	1.15	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	0.51	0.51	0.00	0.51	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.76	0.00	0.71	0.00	2.12	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.70	0.57	2.27	0.57	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	2.08	2.50	0.00	0.00	1.25	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	0.78	0.00	0.78	0.78	0.00	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.97	0.00	0.84	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	0.00	1.39	0.00	0.46	0.00	1.39	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.73	0.67	0.67	0.00	1.34	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.71	1.07	1.07	0.00	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.03	2.02	0.81	0.00	0.40	0.40	0.40	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	0.92	0.92	0.92	0.92	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	0.89	0.89	0.00	0.00	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.40	1.71	0.57	1.14	0.00	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	15.34	1.53	0.77	0.00	0.77	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.13	1.64	1.09	0.55	0.00	0.55	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.94	1.78	2.23	1.34	0.00	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.44	1.30	0.78	1.04	0.52	1.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	0.00	1.33	0.00	0.00	0.66	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	2.08	2.08	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.46	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	0.55	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	8.39	3.01	0.13	2.23	0.26	0.00	0.39	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.86	1.06	1.06	0.53	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	61.80	2.38	1.74	0.00	0.48	0.79	0.95	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	89.23	5.28	4.03	0.42	0.28	1.11	0.97	1.11	0.00
Mammary Epithelial Cell, donor1	11273-116H4	44.84	3.09	0.50	0.00	0.50	0.60	0.20	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	64.28	4.63	1.74	0.29	0.58	1.16	0.29	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	56.87	6.24	1.75	2.24	1.00	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	6.10	0.00	0.68	0.00	1.36	2.03	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.76	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	2.67	1.19	0.00	0.30	0.89	0.30	0.00	0.89	0.00
Mast cell, donor3	11566-120D9	2.70	0.45	0.00	0.23	0.23	0.00	0.23	0.00	0.00
Mast cell, donor4	11567-120E1	5.32	0.71	0.18	0.00	0.35	0.00	0.35	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	26.86	3.68	0.80	0.80	0.30	0.30	0.00	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	72.68	5.19	0.35	0.69	0.00	1.04	0.69	1.38	0.69
Melanocyte - dark, donor3	11663-122F7	25.06	3.69	0.94	0.72	0.22	0.65	0.43	0.36	0.07
Melanocyte - light, donor1	11274-116H5	94.03	11.99	2.12	1.88	2.82	0.94	1.65	1.65	0.00
Melanocyte - light, donor2	11351-117H1	61.42	5.46	0.68	5.46	7.51	0.68	1.36	1.36	0.00
Melanocyte - light, donor3	11423-118G1	68.51	6.07	3.47	0.00	0.87	0.00	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	55.60	6.46	3.85	0.83	1.67	1.15	0.94	0.94	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	48.41	4.03	1.88	2.42	0.54	0.54	0.54	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	73.66	5.89	4.02	4.55	2.95	2.68	2.68	0.54	0.00
Meningeal Cells, donor1	11493-119E8	135.10	15.01	1.98	2.61	0.74	0.87	0.00	0.37	0.00
Meningeal Cells, donor2	11573-120E7	117.52	12.32	4.84	1.32	0.88	3.08	3.52	3.52	0.00
Meningeal Cells, donor3	11654-122E7	103.67	9.86	4.24	2.53	0.49	2.28	0.98	0.57	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.05	5.13	1.43	0.29	0.00	0.00	0.29	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	64.20	3.22	1.51	3.92	0.10	0.70	0.60	0.30	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	208.95	15.77	3.94	10.51	3.94	0.00	2.63	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	60.18	7.85	2.62	2.62	1.31	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	41.62	8.61	5.02	2.87	0.00	0.72	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	84.71	6.14	3.39	5.51	2.33	0.85	1.91	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	52.78	3.02	3.52	1.51	0.50	3.52	1.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	77.79	7.69	0.66	0.44	0.22	0.66	1.32	1.10	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	44.57	8.77	0.73	0.00	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.65	6.34	2.25	0.41	0.20	0.61	0.20	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	47.37	3.05	0.97	0.28	0.14	0.69	0.83	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	178.80	11.15	2.23	1.86	1.49	1.12	1.12	1.12	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	93.02	5.00	2.37	0.79	0.79	0.39	1.05	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	80.42	4.75	2.97	0.59	0.89	0.89	0.89	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	158.82	2.34	2.34	4.67	4.67	4.67	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	43.55	8.33	3.20	0.64	0.64	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	52.81	8.51	0.71	1.42	0.35	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	64.11	5.94	1.88	0.63	1.25	1.25	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.95	4.35	0.00	0.73	0.73	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	156.19	7.16	4.51	1.33	2.39	1.86	1.33	0.27	5.30
Mesothelial Cells, donor2	12156-128G5	117.11	4.00	2.00	0.50	2.00	0.50	0.50	0.00	2.50
Mesothelial Cells, donor3	11402-118D7	234.64	9.03	11.42	0.36	3.97	4.70	3.61	2.17	9.61
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	2.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	2.46	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.75	1.50	0.00	0.00	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2.64	0.61	0.20	0.41	0.00	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.40	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.06	0.42	0.00	0.21	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.19	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.29	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.88	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.27	0.27	0.00	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	0.00	0.00	0.48	0.00	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.98	0.25	0.00	0.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	0.34	0.00	0.00	0.68	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.62	1.78	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.26	1.96	0.28	0.28	0.28	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	1.17	0.00	0.00	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	0.90	0.60	0.00	0.30	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	0.92	0.92	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.09	0.97	0.00	0.28	0.00	0.14	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	11.92	1.30	1.04	0.00	0.00	0.78	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.72	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	11.43	1.27	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.81	0.53	0.27	0.27	0.00	0.00	0.00	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1.50	0.30	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.91	0.71	0.14	0.14	0.28	0.00	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.33	0.00	0.96	0.00	0.00	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.21	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	0.76	0.38	0.38	0.00	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.82	0.00	0.00	0.28	0.28	0.85	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	2.21	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.00	0.29	0.29	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.86	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.48	0.82	1.65	0.82	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.25	0.89	0.60	0.00	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.12	3.95	0.00	1.58	0.00	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.33	0.80	0.53	2.13	0.00	0.27	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.43	1.13	0.34	0.90	0.00	0.11	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	0.00	0.00	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	0.53	0.53	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.37	1.69	1.26	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	97.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	144.77	4.74	2.80	2.80	2.37	1.72	1.94	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	171.42	5.23	7.84	5.23	3.66	3.66	2.09	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	66.75	5.34	0.67	0.67	0.67	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	70.12	11.27	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	33.27	3.42	2.28	1.14	0.38	0.57	1.33	1.14	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	89.37	6.38	0.00	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	63.91	8.16	0.68	0.68	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	9.19	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	35.58	3.77	1.26	0.42	0.42	0.00	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.01	2.09	1.39	0.00	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	61.88	3.78	0.81	0.54	0.00	0.54	0.81	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	54.24	5.47	0.63	1.68	0.42	0.21	0.42	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.26	2.48	0.99	0.99	0.00	0.99	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.11	2.98	1.35	0.00	0.00	0.27	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.70	3.85	0.91	0.23	0.23	0.45	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.36	5.39	0.33	1.31	0.00	0.65	0.33	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.92	5.29	0.55	1.64	0.55	0.18	0.91	1.64	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	57.82	5.83	1.59	0.00	0.53	0.53	1.06	2.65	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	39.62	3.60	0.00	1.80	1.80	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.33	2.30	2.30	0.33	0.98	0.66	1.31	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.35	4.23	0.65	0.16	0.49	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	73.55	5.82	1.23	1.23	0.35	1.23	1.06	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	47.12	3.52	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	62.52	5.98	0.46	0.92	0.46	0.46	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	95.44	5.78	1.93	0.00	0.64	0.96	0.32	1.61	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	1.03	4.83	0.69	0.69	0.69	0.34	2.07	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	2.53	7.59	0.00	5.06	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	67.95	5.35	0.45	1.34	0.00	1.34	0.89	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	73.25	4.23	1.69	0.42	0.85	1.27	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	43.67	3.32	1.42	0.47	0.00	0.95	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	103.45	4.72	1.29	0.00	1.29	0.86	0.00	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	0.00	0.00	9.03	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	105.30	5.00	1.00	0.67	0.00	1.33	0.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	112.72	2.25	0.45	0.45	0.90	0.45	1.35	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	78.17	3.17	0.40	0.79	0.79	1.98	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	75.22	1.86	1.86	0.93	0.93	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	58.27	3.03	2.65	0.38	0.76	1.14	1.14	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	120.58	9.45	1.96	0.98	0.98	0.98	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	132.48	11.33	0.44	3.49	0.00	0.00	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	143.83	7.24	0.45	2.26	0.00	0.45	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	115.53	7.94	0.88	0.88	1.76	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	82.44	1.33	0.00	0.00	0.66	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	137.40	9.92	1.49	0.50	1.49	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	155.43	9.95	1.15	0.77	1.15	0.77	1.53	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	53.23	3.63	2.42	0.30	0.30	1.21	0.00	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	113.61	1.99	0.44	2.87	1.33	0.66	0.66	1.33	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	131.47	8.13	1.36	0.00	2.71	0.68	0.00	3.39	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	20.44	0.00	5.11	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	126.81	3.66	0.00	0.61	1.22	0.00	0.00	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	160.20	7.24	0.63	0.31	0.94	0.31	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	96.55	7.87	1.21	2.12	0.61	0.91	0.91	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	128.16	7.12	4.75	0.79	0.79	1.58	0.79	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	5.67	6.80	1.13	1.13	1.13	2.27	10.20	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	39.88	3.35	0.50	0.75	0.50	0.50	0.50	0.62	0.00
Myoblast, donor2	11322-117D8	57.15	5.56	3.64	0.96	1.34	2.11	0.38	1.53	0.00
Myoblast, donor3	11398-118D3	88.79	5.89	1.68	1.35	0.67	0.67	0.67	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.74	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	96.54	7.26	3.27	1.81	6.53	2.54	1.45	0.00	0.36
Neural stem cells, donor2	11352-117H2	121.32	1.93	5.78	0.00	0.00	0.00	3.85	0.00	0.00
Neurons, donor1	11494-119E9	53.48	1.14	0.00	1.14	0.00	0.00	1.14	1.14	0.00
Neurons, donor2	11574-120E8	27.52	0.44	0.22	0.88	0.44	0.22	0.00	0.00	0.00
Neurons, donor3	11655-122E8	55.09	2.47	4.93	0.82	2.47	0.00	1.64	2.47	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	95.23	10.80	3.68	0.71	0.83	2.49	0.83	1.07	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	68.70	6.84	3.26	1.63	0.98	0.33	0.33	0.98	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	52.14	5.21	1.00	0.00	0.40	0.80	0.00	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	118.24	7.16	3.44	0.96	1.10	2.06	0.96	1.10	0.55
Olfactory epithelial cells, donor2	11934-125I8	127.67	5.36	10.42	0.43	2.46	2.89	4.20	6.22	0.00
Olfactory epithelial cells, donor3	11935-125I9	120.20	4.99	4.09	0.23	1.25	2.04	1.25	1.59	0.00
Olfactory epithelial cells, donor4	11936-126A1	137.14	6.53	1.46	1.85	0.49	1.85	0.97	1.56	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	107.12	9.03	3.01	0.60	0.00	1.20	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	98.05	4.25	1.06	2.98	5.53	0.43	1.70	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	80.02	1.14	6.86	3.43	8.00	1.14	9.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	73.24	6.83	2.48	7.45	3.10	0.00	2.48	2.48	0.00
Osteoblast, donor1	11277-116H8	177.85	15.83	1.95	7.43	1.37	1.37	1.37	0.98	0.78
Osteoblast, donor2	11354-117H4	80.06	8.43	2.11	4.92	0.70	2.81	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	85.31	10.84	2.67	1.60	0.71	0.71	1.07	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	52.14	2.53	2.11	0.93	1.35	1.43	0.76	1.01	0.00
Pericytes, donor1	11491-119E6	184.70	9.12	4.67	15.91	2.45	1.89	2.23	1.89	0.22
Pericytes, donor2	11571-120E5	153.93	11.09	9.96	3.85	2.72	2.72	2.72	1.13	0.00
Pericytes, donor3	11652-122E5	111.29	8.95	3.87	3.26	0.61	2.44	0.81	1.63	0.00
Perineurial Cells, donor1	11499-119F5	59.11	6.22	0.90	1.02	0.23	0.90	0.23	0.79	0.00
Perineurial Cells, donor2	11579-120F4	96.89	5.52	2.12	0.37	0.55	0.46	0.83	0.28	2.48
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.96	0.32	0.32	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	5.63	1.71	0.24	0.00	0.24	0.49	0.73	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.27	1.04	0.13	0.39	0.00	0.26	0.39	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	67.44	2.63	1.20	0.24	1.91	0.96	0.24	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	98.69	7.76	4.44	1.11	2.22	4.44	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	55.36	4.12	2.36	0.98	0.98	0.79	0.39	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	159.49	6.33	10.76	3.80	0.95	5.06	9.18	6.96	0.00
Preadipocyte - breast, donor1	11467-119B9	121.93	3.94	1.31	2.63	3.56	1.13	2.44	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	67.22	3.79	0.91	1.70	0.39	0.65	0.65	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	117.98	9.68	11.03	3.15	3.15	2.70	4.95	3.38	0.23
Preadipocyte - omental, donor1	11468-119C1	169.64	6.93	5.22	1.81	3.41	1.81	3.30	1.28	0.43
Preadipocyte - omental, donor2	11329-117E6	133.12	6.11	3.49	0.00	2.18	1.31	3.06	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	174.05	12.46	4.30	5.87	1.58	2.15	2.29	2.44	0.57
Preadipocyte - perirenal, donor1	11469-119C2	121.06	0.98	3.94	1.97	0.98	0.98	1.97	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	103.81	14.13	0.92	1.84	2.15	0.31	0.92	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	60.38	6.73	4.43	3.72	1.24	2.66	2.12	2.30	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	52.79	9.03	2.89	2.38	1.53	0.68	0.51	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	56.54	5.68	1.12	1.02	0.65	0.65	0.09	0.37	0.00
Preadipocyte - visceral, donor2	11357-117H7	25.31	2.76	5.06	2.30	0.00	2.76	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	43.47	4.28	3.13	2.40	0.31	0.94	0.84	1.57	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	74.37	1.21	3.02	2.56	3.62	1.36	1.36	0.60	0.00
Prostate Epithelial Cells, donor2	11331-117E8	37.64	1.76	2.71	0.27	0.68	1.35	2.71	0.95	0.00
Prostate Epithelial Cells, donor3	11404-118D9	58.67	4.10	4.47	1.22	1.96	1.78	1.84	0.67	0.00
Prostate Stromal Cells, donor1	11254-116F3	100.57	7.06	3.87	0.11	1.59	1.48	1.37	1.48	0.00
Prostate Stromal Cells, donor2	11332-117E9	86.06	5.74	4.66	2.51	1.26	2.51	2.51	1.61	0.18
Prostate Stromal Cells, donor3	11405-118E1	78.73	7.92	4.07	0.52	2.61	1.15	3.13	1.04	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	102.93	12.77	3.65	4.38	2.19	0.73	0.36	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	59.95	5.34	2.01	1.04	0.55	0.62	0.55	0.83	0.42
Renal Epithelial Cells, donor1	11517-119H5	156.23	21.81	2.03	2.03	0.51	0.00	0.00	2.54	0.00
Renal Epithelial Cells, donor2	11597-120H4	98.16	9.25	2.85	3.56	1.42	0.71	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	81.20	6.99	3.18	2.54	0.64	0.95	0.53	0.64	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	120.51	11.57	7.49	5.45	2.72	2.04	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	75.20	5.26	3.10	0.54	0.81	1.62	0.40	0.54	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	81.48	7.99	1.33	1.33	1.11	1.33	1.11	1.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	224.25	13.31	12.64	7.32	3.99	4.66	7.32	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	125.67	14.75	3.52	1.10	0.88	1.10	1.10	0.88	2.42
Renal Mesangial Cells, donor2	11598-120H5	105.96	11.29	4.39	2.51	0.00	0.63	0.63	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	146.75	13.87	5.83	0.00	1.39	1.66	0.28	3.05	3.33
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	94.48	9.93	1.07	1.34	0.54	0.27	1.34	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	67.05	7.17	2.95	2.11	2.11	0.84	0.84	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	106.45	11.57	3.47	1.35	0.39	0.77	0.58	1.16	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	65.60	8.56	1.30	2.85	0.26	1.04	0.00	0.52	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	144.11	8.81	2.27	8.53	1.42	0.85	1.42	0.85	5.40
Retinal Pigment Epithelial Cells, donor2	11608-120I6	79.24	7.20	3.09	0.00	0.00	1.03	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	130.22	5.52	4.27	2.26	2.76	3.76	2.01	0.75	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	102.50	5.08	2.27	0.53	2.00	0.67	0.40	2.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	83.09	6.25	0.89	0.00	2.68	1.79	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	3.30	6.60	0.00	8.81	3.30	1.65	3.30	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	59.75	3.48	0.58	1.74	4.06	2.32	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	90.63	2.99	3.64	0.65	0.78	0.78	0.91	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	113.01	8.54	5.06	1.29	1.49	1.59	1.79	2.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	114.66	6.92	1.12	1.00	0.67	0.67	0.33	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	102.71	4.22	7.19	1.86	0.99	2.48	0.87	1.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	140.44	8.39	7.46	1.86	1.52	3.26	2.68	1.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	114.18	5.55	5.32	1.62	0.92	0.92	0.46	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	100.08	4.93	3.56	0.96	0.68	1.10	0.96	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	123.89	5.90	8.17	1.51	1.21	2.57	3.63	4.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	97.84	7.71	0.18	1.08	0.54	0.00	0.72	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	108.88	4.73	2.87	0.29	0.57	1.86	0.72	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	117.72	8.48	6.22	1.61	1.50	2.04	2.68	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	120.59	9.07	5.97	1.99	1.55	0.89	1.77	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	111.46	4.59	2.49	0.38	0.76	0.96	1.34	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	135.55	9.78	4.38	1.68	0.65	1.96	0.75	2.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	143.75	6.01	1.88	1.50	1.13	0.75	0.19	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	130.19	5.31	1.99	1.46	0.53	1.33	1.33	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	151.07	8.96	6.52	1.56	0.97	2.14	1.56	3.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	128.32	10.12	4.39	1.53	1.15	0.76	1.15	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	132.96	5.98	3.74	0.96	1.07	0.75	1.17	1.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	130.90	8.69	7.85	1.68	1.12	4.48	2.80	5.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	125.78	7.01	4.27	1.54	1.03	0.85	0.85	2.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	113.23	3.83	1.64	1.09	1.09	0.55	0.36	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	149.24	10.06	12.14	2.82	2.21	3.56	1.96	3.43	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	127.87	9.00	7.12	1.88	1.75	1.88	1.61	2.28	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	135.63	1.89	4.48	1.42	1.65	1.65	1.65	2.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	162.10	10.71	9.92	2.18	2.38	3.37	3.37	3.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	142.65	7.95	6.55	1.40	1.40	2.34	0.94	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	129.80	4.77	4.56	0.83	1.24	0.83	1.66	1.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	138.92	7.74	9.73	1.55	2.43	4.65	4.65	4.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	134.52	8.56	3.34	1.46	1.46	1.88	0.21	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	133.24	4.71	2.15	1.75	1.48	1.75	0.40	1.35	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	128.57	9.88	2.72	2.38	0.85	0.85	0.85	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	137.08	9.06	5.40	1.16	0.58	1.16	1.35	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	105.57	2.75	7.57	1.20	2.75	2.06	0.69	2.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	125.65	8.23	2.19	0.82	0.96	0.82	0.96	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	108.68	7.06	4.43	0.82	0.82	1.31	0.99	2.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	78.74	1.87	4.09	0.85	1.36	1.36	1.19	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	112.00	9.17	3.99	1.18	0.30	2.07	0.44	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	108.75	4.26	3.73	1.33	0.27	1.07	0.27	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	104.25	3.18	3.04	0.83	0.83	0.55	0.69	0.97	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	79.76	4.29	4.52	1.43	0.24	0.00	0.00	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	133.62	11.49	1.81	0.40	1.21	2.62	0.60	0.81	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	92.67	3.30	5.46	2.54	2.26	1.88	1.04	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	113.89	8.38	6.29	2.10	3.49	1.75	1.40	2.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	101.54	4.84	2.12	3.32	0.91	0.00	0.30	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	88.98	3.55	4.90	1.35	3.30	1.35	1.96	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	119.79	5.39	1.31	1.89	0.44	0.73	0.58	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	96.13	7.91	1.83	2.43	4.87	0.00	1.22	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	65.10	2.11	4.22	0.90	3.01	0.90	1.51	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	131.64	8.14	8.14	3.39	8.37	2.04	1.36	2.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	129.70	7.19	5.69	2.10	3.59	1.50	0.60	1.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	118.31	4.37	6.49	2.72	13.34	0.83	2.83	7.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	123.37	8.32	5.98	2.99	15.37	1.28	5.34	7.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	97.96	9.01	3.00	1.20	5.41	1.20	1.80	2.40	0.00
Schwann Cells, donor1	11498-119F4	99.49	8.84	4.89	3.76	0.75	2.07	1.13	1.50	0.19
Schwann Cells, donor2	11578-120F3	30.62	3.40	6.80	6.80	0.00	0.00	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	45.57	5.48	1.31	3.07	0.44	0.66	0.44	0.88	0.22
Sebocyte, donor1	11220-116B5	307.30	20.27	6.03	5.48	2.74	1.64	1.10	0.55	0.00
Sebocyte, donor2	11301-117B5	134.19	8.73	13.79	0.92	4.14	2.76	3.22	0.46	0.00
Sebocyte, donor3	11378-118B1	148.40	13.19	7.63	0.21	4.12	3.71	2.27	1.86	0.00
Sertoli Cells, donor1	11255-116F4	115.96	9.94	1.66	0.00	1.66	3.31	0.00	4.97	0.00
Sertoli Cells, donor2	11333-117F1	64.96	2.82	8.47	2.82	0.00	0.00	8.47	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	225.75	17.68	5.98	2.20	7.13	2.11	2.64	2.82	0.09
Skeletal Muscle Cells, donor2	11358-117H8	156.13	19.52	7.95	3.61	6.51	2.89	4.34	7.95	0.00
Skeletal Muscle Cells, donor3	11430-118G8	168.88	17.56	5.85	1.67	5.02	3.34	0.84	4.18	0.00
Skeletal Muscle Cells, donor4	11451-119A2	63.62	6.13	2.04	0.47	0.16	1.41	0.94	1.41	0.00
Skeletal Muscle Cells, donor5	11455-119A6	69.71	7.28	2.97	0.30	0.45	0.30	0.59	1.19	0.00
Skeletal Muscle Cells, donor6	11459-119B1	77.11	11.08	2.62	1.69	1.54	1.23	0.77	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	68.30	8.19	1.64	1.51	1.01	1.13	0.76	1.01	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	78.05	9.99	3.85	0.71	1.28	2.57	1.43	1.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	98.91	11.61	3.37	1.19	0.40	1.39	0.69	0.79	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	197.40	10.95	4.30	1.18	2.61	2.36	2.02	1.60	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	245.36	20.27	7.24	2.17	2.17	5.07	2.17	5.07	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	66.32	5.37	3.16	2.48	0.96	1.79	1.10	1.10	0.00
Skin - palm, donor1	10286-104F7	51.04	2.69	0.00	0.00	5.37	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.47	2.88	1.59	0.14	1.01	0.86	0.58	1.30	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.17	0.82	0.82	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	42.06	2.60	1.04	0.26	0.39	1.30	0.78	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	86.18	4.17	3.34	0.70	2.50	1.81	1.39	2.09	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	107.04	5.91	3.52	0.98	2.25	1.55	3.24	3.52	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	47.15	2.33	0.00	0.00	0.00	0.63	0.42	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	98.86	5.10	3.37	0.60	0.97	1.35	1.65	0.75	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	60.17	1.54	4.63	0.00	1.54	1.23	0.93	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.01	0.89	0.67	0.44	0.22	0.44	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	46.44	7.05	0.59	0.59	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.58	6.85	2.21	4.20	1.55	1.10	0.88	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	71.67	4.33	0.79	0.00	0.39	1.18	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.04	6.18	0.77	0.00	0.77	0.77	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	10.01	2.00	0.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	87.43	4.79	1.86	1.20	1.06	0.40	0.80	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	48.32	4.65	4.21	2.66	0.44	1.33	0.89	1.11	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	40.07	1.28	0.90	0.13	0.38	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	4.88	0.33	2.93	0.00	0.33	0.33	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	75.01	3.84	1.77	0.30	0.30	0.59	0.30	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	69.33	8.40	1.85	1.57	0.57	0.28	0.71	0.85	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	85.24	9.60	0.49	0.81	0.98	0.81	0.65	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	72.76	6.09	2.74	1.52	0.61	0.30	0.61	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	63.14	8.84	1.26	6.57	1.01	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	6.12	0.00	0.00	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	96.80	8.11	4.77	1.43	2.86	0.48	1.43	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	37.16	4.28	1.18	1.03	0.29	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	43.05	3.23	2.37	0.22	0.43	1.08	1.51	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	53.42	6.61	1.26	0.31	0.63	1.36	1.05	0.84	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	85.23	5.88	0.46	1.24	1.24	0.31	0.31	0.62	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	80.84	4.31	1.08	2.16	1.08	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.04	3.29	0.60	1.20	0.30	0.00	0.30	1.20	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	122.22	15.02	1.02	1.02	0.34	0.68	1.37	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.35	6.20	0.86	0.55	0.24	0.55	0.24	0.55	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	118.86	5.23	6.84	2.42	7.65	1.61	4.73	2.11	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	49.38	4.78	2.73	2.28	0.23	1.82	0.23	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	65.21	3.02	4.83	0.00	0.60	1.81	1.81	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.47	10.07	3.18	0.79	0.26	0.53	0.53	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	56.19	3.73	2.13	2.80	1.33	0.93	0.27	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	70.50	4.51	6.26	0.38	2.00	3.26	2.50	1.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	40.59	4.06	1.27	1.27	0.51	0.51	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.95	6.18	0.90	0.75	1.21	0.00	0.30	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	45.01	3.75	0.75	3.00	1.50	2.25	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	78.83	1.29	1.29	0.00	6.46	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	68.83	11.16	0.93	4.19	2.33	0.47	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	83.81	8.08	4.04	3.03	2.02	2.02	1.51	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	88.69	5.95	3.13	2.51	4.70	1.25	1.25	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	45.43	4.72	1.47	1.47	0.59	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	52.48	7.16	0.08	0.50	0.08	0.00	0.00	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.23	8.88	1.87	0.00	0.47	0.00	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	81.31	5.76	1.15	1.44	1.15	0.14	0.29	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	88.21	6.88	4.59	1.53	1.02	1.02	0.76	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.39	6.58	2.26	0.94	0.75	0.75	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.41	7.55	1.68	0.28	0.28	0.98	0.28	0.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	84.29	6.20	1.42	0.50	0.17	0.92	0.84	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	44.76	12.38	1.90	0.48	0.48	0.95	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	75.60	6.61	0.98	2.45	0.98	0.24	0.73	1.22	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	69.38	5.30	3.31	1.33	2.65	0.88	1.10	0.66	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	41.84	5.85	1.46	1.46	1.17	0.29	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	32.07	1.75	0.39	0.39	1.17	0.39	1.17	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	28.83	2.12	2.12	0.53	0.79	1.06	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.16	1.12	2.23	0.00	2.98	2.60	0.74	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	40.61	1.44	4.31	0.36	1.08	2.52	1.80	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	31.51	1.99	0.85	0.28	0.00	1.14	1.14	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	57.50	3.94	1.18	0.39	0.00	1.97	0.00	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	22.60	0.76	1.52	1.02	2.29	1.02	2.29	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	18.77	3.99	0.80	0.80	1.60	0.80	1.20	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	37.20	3.76	2.93	0.00	0.42	1.25	1.25	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	25.67	1.83	0.46	0.46	0.00	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	117.82	4.21	4.71	5.39	2.36	1.01	0.84	1.35	0.50
Synoviocyte, donor2	11368-117I9	51.80	4.69	3.35	1.51	1.01	0.67	0.17	0.17	0.00
Synoviocyte, donor3	11440-118H9	54.74	3.80	4.02	0.67	1.34	0.89	0.67	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	95.05	11.08	2.14	1.07	0.00	1.79	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	283.43	11.89	15.86	0.00	0.00	0.00	7.93	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	189.41	23.15	5.56	1.16	1.16	1.16	1.62	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	84.59	7.53	0.65	1.08	1.22	0.43	0.14	0.50	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	75.77	9.66	2.32	2.32	1.16	0.39	0.77	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	170.65	11.45	8.02	2.29	2.86	2.29	1.72	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	111.09	3.69	2.09	1.35	2.58	0.98	0.12	1.72	0.12
Urethra, donor2	10319-105A4	35.97	7.19	0.00	0.00	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	60.31	7.17	2.13	1.33	0.80	0.27	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	47.27	2.00	0.80	0.40	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	40.57	4.13	1.15	0.92	0.23	0.46	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	44.80	6.02	1.34	0.67	0.22	1.11	0.22	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	0.89	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	1.43	1.43	0.00	1.43	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	0.00	0.00	1.37	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	5.85	0.69	0.00	0.34	0.69	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	5.23	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	4.59	0.92	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	0.00	0.91	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	66.86	7.53	1.85	3.33	0.49	0.99	0.62	0.49	0.00
Wilms' tumor cell line:HFWT	10597-108E3	55.44	7.04	0.88	0.88	0.00	0.00	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	55.03	2.23	0.84	0.56	0.28	0.00	1.12	0.00	0.00
achilles tendon, donor2	10292-104G4	31.00	4.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	16.70	4.27	0.39	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.57	3.88	0.52	2.59	0.52	0.26	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.38	5.55	2.05	2.34	0.29	1.17	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.93	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.76	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.12	1.71	1.28	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.82	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.33	0.48	0.00	0.24	0.24	0.00	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	184.16	11.77	1.88	0.71	1.18	0.94	0.94	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	53.05	5.43	2.48	2.95	2.95	0.78	0.31	1.24	0.00
adipose, donor1	10184-103D4	8.80	1.17	1.76	0.59	1.17	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	41.77	4.87	2.03	0.81	2.43	0.81	2.84	0.81	0.00
adipose, donor3	10186-103D6	25.05	2.18	1.09	0.54	1.91	0.27	0.00	0.82	0.00
adipose, donor4	10187-103D7	19.07	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	6.63	4.26	0.16	0.32	0.00	0.32	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	69.12	0.00	0.00	3.64	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.94	2.86	1.43	0.36	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	91.35	2.09	0.93	1.16	0.93	0.70	1.16	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	40.23	0.68	0.34	1.35	1.01	0.00	0.68	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	46.84	1.18	1.18	1.77	0.88	0.29	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	48.62	0.00	3.56	0.00	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	84.76	3.65	2.43	1.82	1.42	2.03	1.22	0.20	1.82
amygdala, newborn, donor10223	10360-105E9	19.37	0.97	0.32	0.00	0.00	0.32	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	69.39	7.51	1.53	0.25	1.15	0.51	0.76	0.51	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	88.25	6.40	0.66	0.44	1.10	0.66	0.44	1.10	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.33	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	88.26	6.67	2.16	1.96	0.98	0.59	0.39	0.78	0.20
appendix, adult	10189-103D9	39.20	4.27	0.39	1.16	0.00	0.00	0.78	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	35.33	2.72	2.72	0.00	0.00	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	110.10	14.78	1.30	1.30	1.01	0.72	0.43	0.72	0.72
b cell line:RPMI1788	10427-106D4	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	129.57	6.94	2.22	0.55	1.11	1.66	1.94	1.94	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	106.67	6.45	1.79	3.08	0.69	0.79	0.40	0.60	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	185.46	6.03	2.68	1.34	1.51	1.34	0.50	0.67	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	5.59	1.12	0.56	0.00	0.00	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	45.41	6.41	2.17	2.50	1.41	0.43	0.87	0.54	0.00
blood, adult, pool1	10053-101G8	2.21	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	111.33	3.43	0.00	0.86	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	55.34	5.40	4.05	0.67	0.00	1.35	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	96.36	1.03	2.05	4.10	2.05	1.03	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	135.97	3.56	4.34	2.45	1.89	1.34	0.67	0.56	4.23
brain, fetal, pool1	10085-102B4	29.39	2.67	2.67	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	52.53	2.97	0.99	0.33	0.66	0.66	0.99	1.32	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	109.59	3.37	0.62	2.37	0.25	0.87	0.37	0.25	0.12
breast, adult, donor1	10080-102A8	88.39	5.05	1.26	0.00	6.31	0.63	1.26	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	66.31	13.97	2.54	2.92	1.27	1.27	0.38	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	73.90	8.35	2.16	0.62	1.24	0.93	0.93	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	3.68	1.15	0.92	0.00	0.46	0.46	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.83	2.18	0.48	0.73	0.24	0.24	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	6.58	3.76	0.47	0.00	0.47	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	40.47	4.27	0.11	0.55	0.11	0.00	0.44	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.27	5.59	1.86	0.80	0.27	2.13	0.80	1.86	0.00
caudate nucleus - adult, donor10196	10177-103C6	102.47	0.00	3.45	0.00	2.30	0.00	0.00	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	54.72	3.01	1.34	1.17	0.17	2.34	0.17	0.17	1.17
caudate nucleus, adult, donor10258	10379-105H1	32.09	2.29	1.53	0.76	0.00	0.00	0.76	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	30.40	1.46	0.73	1.10	0.37	0.73	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	55.35	2.91	0.00	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.75	2.14	1.92	0.43	0.21	0.64	0.85	0.43	0.64
cerebellum, adult, pool1	10083-102B2	25.18	2.07	0.34	1.03	0.00	0.34	0.00	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	14.11	0.00	0.83	0.00	0.83	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	31.01	1.26	1.51	0.00	0.25	0.25	0.00	0.50	1.26
cerebrospinal fluid, donor2	10294-104G6	19.00	2.92	0.00	0.00	0.00	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	124.66	8.91	1.29	2.16	1.15	0.86	1.01	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	71.26	2.98	0.17	0.50	0.66	0.17	0.50	0.66	0.00
cervix, adult, pool1	10013-101C4	104.78	12.70	2.83	1.99	2.31	0.94	1.26	1.99	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.90	2.93	0.84	0.56	0.70	0.14	0.28	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	112.34	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	57.54	2.49	1.86	0.62	2.36	1.12	1.24	1.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	92.78	3.70	1.48	0.62	0.74	0.62	0.25	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	152.03	7.12	0.71	1.42	1.66	0.95	1.90	1.90	0.00
chorionic membrane cells, donor1	12238-129G6	168.10	1.71	2.28	0.85	2.85	0.28	3.13	1.71	0.28
chorionic membrane cells, donor2	12239-129G7	116.14	4.57	2.98	1.69	4.97	1.59	2.78	1.69	0.10
chorionic membrane cells, donor3	12240-129G8	237.38	1.10	10.44	0.55	12.64	6.04	5.49	8.79	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.48	2.50	0.38	1.15	0.19	0.19	0.19	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	36.21	4.37	1.54	0.26	1.03	0.51	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	48.38	5.81	2.18	0.48	0.73	0.48	0.48	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	41.94	4.07	3.66	0.41	0.00	1.02	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	55.65	4.12	1.77	0.00	0.00	0.29	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.86	8.23	3.43	0.69	1.14	1.83	0.91	1.14	0.00
clear cell carcinoma cell line:TEN	10636-108I6	1.91	0.17	0.00	0.00	0.17	0.00	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	49.97	3.66	1.65	0.92	0.37	0.55	0.37	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	137.97	25.09	5.32	1.52	0.00	1.90	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	67.83	2.38	2.38	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	53.93	6.82	0.94	2.23	1.76	0.59	0.59	1.29	0.00
colon, fetal, donor1	10070-101I7	58.71	5.56	0.62	0.62	3.09	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	9.81	0.91	0.45	0.00	0.30	0.00	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	8.18	1.83	0.00	0.14	0.14	0.14	0.00	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	500.52	7.85	8.51	5.42	2.21	3.10	1.55	1.99	18.24
cruciate ligament, donor2	10295-104G7	35.66	4.05	0.81	0.81	0.00	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	57.78	7.22	1.61	0.80	0.80	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	127.91	2.16	7.20	0.72	2.40	2.64	0.96	1.92	5.52
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	71.03	2.56	0.26	0.26	0.00	0.00	0.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.29	4.57	1.69	0.96	0.48	0.48	0.48	0.48	0.00
ductus deferens, adult	10196-103E7	40.37	4.49	1.99	1.00	1.00	0.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	89.29	7.20	2.88	0.00	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	79.45	6.62	5.89	0.74	0.74	5.89	0.00	1.47	0.00
dura mater, adult, donor1	10041-101F5	67.47	8.42	1.32	1.32	0.66	0.58	0.17	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	538.75	11.10	16.88	3.11	32.20	6.88	9.10	9.77	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.10	3.58	0.57	1.72	0.29	0.29	0.29	0.57	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	106.06	11.72	0.00	0.62	0.00	0.00	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	81.73	6.36	1.82	0.30	0.30	0.30	0.30	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	145.42	8.34	0.31	0.62	0.31	0.31	1.23	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	112.96	6.57	1.31	0.00	1.31	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	71.06	6.70	1.01	0.34	0.00	0.34	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	221.65	27.91	3.08	1.45	2.36	1.09	2.17	1.45	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.89	2.25	0.96	0.32	0.16	0.96	0.32	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	141.06	6.34	1.00	3.67	1.33	0.44	0.33	0.67	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	132.31	8.14	1.87	0.88	0.66	0.88	0.55	0.33	0.55
epididymis, adult	10197-103E8	33.28	5.44	2.09	0.84	2.51	0.84	0.63	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.24	6.56	0.71	0.53	0.00	0.00	0.53	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	51.12	1.57	0.39	0.00	1.97	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	93.44	4.85	4.72	2.36	0.39	2.62	0.79	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	167.31	5.22	8.27	1.67	2.36	4.53	2.07	0.98	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	93.21	3.25	4.03	2.80	0.56	2.02	1.79	1.34	0.00
esophagus, adult, pool1	10015-101C6	71.35	4.88	3.19	0.85	0.96	0.85	0.53	0.85	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	319.10	16.03	3.63	1.38	3.63	2.25	2.63	1.75	1.25
eye - muscle inferior rectus, donor1	10272-104E2	36.22	2.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	2.10	0.00	0.00	2.10	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	34.23	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	53.89	8.03	0.00	0.00	0.00	0.00	0.00	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	16.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	41.19	3.81	2.80	0.25	0.00	0.51	0.00	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	100.27	18.59	1.67	0.90	1.03	1.15	0.90	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.78	6.41	0.47	0.71	0.24	0.00	0.71	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	98.33	1.88	1.31	1.69	0.28	0.66	0.28	0.38	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	107.49	2.40	2.10	3.60	1.20	0.30	0.90	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.70	5.21	0.82	1.55	0.55	0.73	0.37	0.46	0.37
gall bladder, adult	10198-103E9	161.52	6.52	6.76	8.93	4.83	1.69	4.10	3.38	0.97
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	42.24	2.32	2.75	0.00	0.84	1.06	0.21	1.06	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	98.26	3.67	1.16	0.19	0.19	0.77	0.97	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	90.67	10.33	1.15	0.82	0.16	0.49	0.49	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3.20	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	63.91	9.87	1.49	3.21	1.38	1.26	0.57	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	22.81	6.58	0.42	0.14	0.14	0.14	0.00	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	83.56	1.50	0.50	0.75	1.00	0.00	0.50	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.54	5.17	0.42	1.58	0.00	0.42	0.32	0.42	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	52.52	5.06	0.56	0.84	0.42	0.14	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	117.33	8.61	1.21	0.22	0.88	0.55	0.99	0.99	0.33
glioma cell line:GI-1	10413-106B8	38.66	6.44	1.17	0.00	0.59	1.46	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	182.23	5.10	2.19	1.46	0.73	1.46	0.00	0.00	4.37
globus pallidus, adult, donor10252	10161-103A8	259.96	6.10	7.08	1.22	2.69	3.17	2.44	2.44	7.32
globus pallidus, adult, donor10258	10367-105F7	149.24	4.11	1.37	1.37	4.11	4.11	4.11	6.85	4.11
globus pallidus, newborn, donor10223	10364-105F4	68.21	0.53	2.13	0.53	1.60	1.07	0.53	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	85.76	5.44	1.60	0.64	0.64	0.32	1.60	0.96	1.28
hIPS +CCl2, biol_rep1	14383-156B9	17.45	2.30	0.92	3.21	0.92	1.38	0.46	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	23.78	1.37	0.00	3.20	0.91	0.91	0.91	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	21.26	1.29	2.58	2.58	0.00	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	15.81	0.00	1.44	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	21.26	2.06	0.00	0.69	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	46.35	0.00	2.21	2.21	0.00	0.00	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	68.76	5.08	3.29	1.79	0.90	0.30	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	76.61	5.23	2.09	1.83	1.31	1.57	0.52	1.31	0.00
heart - tricuspid valve, adult	10207-103F9	114.07	6.66	3.33	2.50	5.00	0.83	2.50	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	65.50	3.26	3.67	1.22	1.84	1.84	1.63	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	32.79	5.54	0.85	1.70	0.43	0.85	0.00	1.28	0.00
heart, adult, pool1	10016-101C7	48.07	4.83	0.23	0.23	0.69	0.00	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	83.68	5.44	1.13	1.75	0.41	0.62	0.62	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	98.11	10.18	1.54	3.09	0.31	0.62	0.93	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	168.40	9.94	7.62	1.44	1.33	2.87	1.22	2.65	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	154.39	8.13	10.07	2.79	1.46	3.76	1.34	2.31	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	185.84	11.12	9.30	2.02	1.41	5.15	1.41	1.72	0.10
hepatoma cell line:Li-7	10484-107A7	186.29	4.56	3.56	1.67	1.67	1.78	1.11	1.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	49.21	2.84	0.95	0.00	0.95	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	115.11	4.29	4.69	1.02	0.82	3.47	0.20	0.82	1.43
hippocampus, adult, donor10258	10374-105G5	23.40	0.50	0.00	0.00	0.50	1.99	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	31.72	0.35	0.00	0.70	1.06	0.00	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.48	1.37	0.00	0.00	0.20	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.62	1.78	0.25	0.76	0.51	0.00	0.51	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	17.48	2.82	2.82	0.00	0.00	0.56	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.46	4.13	2.07	0.26	3.36	0.52	1.55	2.07	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.98	2.28	1.52	1.14	2.28	0.38	2.28	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	24.52	2.63	1.46	0.00	2.92	0.00	0.29	1.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.47	1.51	2.37	0.65	5.82	1.08	2.80	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.28	2.92	0.42	0.83	2.92	0.42	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.21	1.89	0.71	0.47	2.37	0.00	0.24	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	37.93	3.05	1.45	0.96	3.05	0.32	1.77	1.29	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	0.67	0.67	0.00	3.37	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.67	1.25	0.47	1.10	0.47	0.00	0.63	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.42	0.00	0.49	0.98	0.98	0.00	0.49	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	0.00	0.87	0.00	0.00	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.85	2.86	0.57	0.95	3.05	0.00	1.53	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	1.31	0.00	1.31	0.44	0.44	1.31	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	1.00	1.50	1.00	3.00	0.00	1.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.82	2.45	2.07	0.38	2.45	1.32	1.51	1.70	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	47.75	3.18	2.73	0.45	5.46	0.45	0.45	2.27	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.84	3.13	3.76	0.31	4.07	0.00	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	30.37	2.94	0.98	1.47	4.74	1.14	0.98	0.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.71	1.45	2.61	2.32	2.61	1.16	1.16	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.08	2.99	3.89	2.09	4.78	0.90	0.60	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.12	2.22	1.66	0.37	1.29	0.00	0.37	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.83	3.14	0.86	0.00	1.14	0.29	0.57	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.07	1.22	0.82	0.41	2.04	0.00	0.82	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	18.31	1.76	1.06	0.00	2.11	0.70	1.41	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.47	1.90	1.58	0.63	2.53	1.27	0.32	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.07	1.51	1.21	0.61	3.33	0.00	0.61	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	2.07	1.55	0.00	1.55	0.00	0.00	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	26.57	1.99	0.66	0.00	0.66	0.00	0.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.08	2.31	0.00	0.51	0.00	0.51	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.37	0.77	3.83	0.26	2.05	0.26	1.28	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	2.27	0.76	0.00	0.76	0.76	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.38	2.69	1.68	0.67	1.68	0.00	1.68	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.04	1.69	0.00	0.00	0.72	0.72	0.24	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.47	0.00	0.45	0.00	0.45	0.00	0.89	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.68	2.44	1.95	0.00	0.98	0.49	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.31	2.14	0.92	0.00	2.14	0.31	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	0.00	3.25	0.00	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	12.91	1.99	2.32	0.33	2.32	0.00	0.66	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	32.29	1.64	1.64	1.09	0.55	1.09	1.09	3.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.57	1.81	0.72	0.00	2.17	0.36	0.00	2.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.22	0.71	0.71	0.00	2.14	0.36	1.07	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	0.00	2.39	0.00	1.19	0.00	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	37.24	2.84	1.90	0.81	5.69	0.54	1.35	2.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.21	1.89	1.89	0.27	1.62	0.54	0.27	0.00	0.00
immature langerhans cells, donor1	11904-125F5	6.30	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.48
immature langerhans cells, donor2	11905-125F6	21.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	86.97	2.37	0.85	1.89	0.47	0.47	0.19	0.28	2.84
keratoacanthoma cell line:HKA-1	10791-110H8	52.67	1.95	0.65	0.98	0.65	0.33	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	51.17	4.01	0.70	1.30	1.30	0.50	0.10	0.20	0.10
kidney, fetal, pool1	10045-101F9	113.11	12.87	1.84	1.98	0.42	0.64	0.42	0.50	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.90	5.40	0.85	0.43	0.28	0.43	0.14	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.85	1.38	0.97	0.00	0.55	0.83	0.28	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	121.48	6.79	0.37	0.37	0.37	0.00	0.37	0.00	0.00
left atrium, adult, donor1	10079-102A7	37.59	1.63	0.00	0.54	1.09	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	30.84	4.05	0.51	0.51	2.53	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	22.16	1.09	0.27	0.00	0.27	0.27	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	28.02	1.80	1.44	2.16	0.36	0.72	0.00	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	39.67	1.09	1.09	1.09	1.09	0.54	0.00	3.26	0.54
leiomyoma cell line:15425	10571-108B4	30.84	2.43	4.13	0.49	1.21	2.43	0.97	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00	0.00	0.00	6.35	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	89.92	4.18	3.14	1.05	2.09	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	68.12	8.62	0.59	1.89	0.59	0.59	0.47	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	17.50	2.19	0.94	0.47	0.16	0.31	0.16	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	85.65	8.41	1.95	0.73	0.37	0.37	0.12	0.73	0.12
liver, adult, pool1	10018-101C9	236.77	5.83	5.83	0.97	13.29	2.11	1.94	5.67	2.76
liver, fetal, pool1	10086-102B5	81.84	3.76	2.82	0.94	2.82	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	151.37	4.37	2.19	0.73	1.31	3.21	1.60	1.17	3.94
locus coeruleus, adult, donor10252	10165-103B3	158.71	4.61	3.69	1.11	1.11	2.58	1.66	1.66	4.43
locus coeruleus, adult, donor10258	10375-105G6	112.01	3.95	2.82	1.69	1.69	2.54	1.41	3.10	1.41
locus coeruleus, newborn, donor10223	10362-105F2	18.93	1.26	3.36	0.42	3.79	1.26	2.52	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	40.96	2.35	0.28	0.83	0.14	0.14	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	127.54	6.89	0.00	2.76	0.00	0.00	1.38	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	126.94	9.62	1.45	1.05	0.79	0.66	1.32	0.79	0.53
lung, adult, pool1	10019-101D1	75.48	8.98	1.42	2.60	2.84	0.59	1.18	1.18	0.00
lung, fetal, donor1	10068-101I5	114.73	5.99	3.42	1.43	1.71	0.86	1.14	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	46.28	5.04	3.67	0.46	0.92	0.46	0.46	3.21	0.00
lymph node, adult, donor1	10077-102A5	22.72	3.31	1.89	2.37	0.47	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	6.36	2.19	0.00	0.00	0.22	0.22	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.30	0.00	0.15	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	439.19	11.89	2.55	1.70	8.49	0.85	3.40	0.00	0.00
mature adipocyte, donor1	12231-129F8	51.50	5.77	0.00	7.55	0.00	0.89	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	100.03	3.74	0.21	6.64	0.62	0.42	0.42	0.83	0.00
mature adipocyte, donor3	12233-129G1	72.54	4.03	1.19	6.16	0.47	0.47	1.42	0.24	0.00
mature adipocyte, donor4	12234-129G2	32.64	1.58	0.53	3.16	0.53	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	102.93	6.19	1.67	1.43	2.38	0.48	0.24	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	41.74	1.13	1.13	0.00	0.00	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	82.39	2.57	2.76	0.92	0.55	2.39	0.00	0.00	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	31.13	1.27	0.32	0.95	0.00	0.00	0.00	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	1.71	0.00	0.43	0.43	0.43	0.00	0.43	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	59.74	1.52	2.87	0.00	0.51	2.19	1.35	0.68	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	113.96	2.55	3.82	0.42	1.27	1.91	0.85	0.21	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.28	0.72	0.36	0.36	0.36	0.36	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	79.82	5.84	2.60	0.00	1.30	1.30	0.00	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	135.14	4.02	7.43	0.93	0.93	2.63	1.70	0.93	6.19
medulla oblongata, adult, pool1	10038-101F2	224.23	7.10	1.88	2.37	0.90	1.06	0.90	0.49	6.04
medulla oblongata, newborn, donor10223	10361-105F1	60.41	2.08	1.74	2.08	0.69	0.69	2.08	1.04	1.74
medulloblastoma cell line:D283 Med	10838-111E1	3.76	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	56.86	5.87	0.24	0.49	0.37	0.12	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	110.25	7.33	2.01	0.57	4.60	0.86	1.29	0.43	0.00
melanoma cell line:G-361	10465-106H6	2.99	0.27	0.27	0.00	0.27	0.00	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	38.17	2.35	2.35	1.09	0.54	0.90	1.81	1.63	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	3.89	1.04	0.26	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	45.26	3.99	2.92	1.23	0.15	1.38	0.61	1.07	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	77.98	5.09	5.27	0.91	1.27	2.00	0.55	1.82	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	2.48	1.66	0.83	1.66	0.41	1.66	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.33	3.65	1.83	1.26	0.42	0.56	0.14	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	38.13	3.27	2.12	0.39	0.58	0.39	0.39	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	68.02	3.47	0.69	0.00	2.08	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	39.30	3.60	2.57	1.72	1.54	0.69	0.34	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	55.78	4.14	2.42	4.03	1.50	1.04	0.81	0.92	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.15	1.99	1.19	0.27	0.13	0.53	0.40	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.50	2.03	0.81	1.08	0.00	0.14	0.41	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.13	3.27	0.85	0.14	0.14	0.43	0.43	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	31.29	3.29	0.99	0.33	0.66	0.66	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	41.93	4.43	1.38	1.38	0.42	0.69	0.14	0.97	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.29	1.75	1.05	2.44	0.35	0.00	1.40	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.72	3.47	1.63	0.41	0.20	0.82	0.61	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.21	4.67	3.24	0.36	1.44	1.08	1.44	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	63.83	5.28	3.41	0.72	0.31	0.72	0.41	0.31	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	88.69	2.96	4.33	0.46	1.60	0.91	2.51	1.37	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.24	0.42	1.68	0.00	0.00	0.84	0.00	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.37	2.09	0.75	1.05	0.90	0.30	0.30	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	76.06	5.08	4.73	0.79	1.14	0.70	0.88	1.31	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.20	4.05	1.10	0.37	0.37	0.74	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	52.08	4.29	2.00	1.14	1.43	1.72	0.57	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	95.57	5.05	4.21	1.68	2.11	1.68	2.95	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	73.07	3.20	2.28	0.46	1.37	0.46	0.46	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	75.71	4.86	1.79	0.77	1.02	2.30	2.05	1.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	81.93	6.28	4.19	0.52	1.83	0.26	1.57	1.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	80.41	4.01	1.85	0.92	0.92	1.23	1.85	2.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	70.84	4.47	4.71	0.47	2.59	1.65	1.65	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	80.55	7.11	4.40	0.68	2.03	1.35	1.02	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	84.49	3.93	2.75	1.18	0.79	1.57	1.96	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	79.70	3.24	2.32	0.46	0.93	1.39	2.32	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	79.03	6.35	1.44	0.87	1.44	1.15	0.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	74.96	6.92	3.12	0.67	1.56	0.89	1.12	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	75.23	6.97	1.92	1.44	0.72	1.44	2.40	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	93.87	6.60	0.73	1.47	0.73	0.73	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	62.77	3.69	1.34	1.34	2.01	0.67	0.34	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	66.73	4.91	3.28	0.82	1.64	1.23	1.23	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	60.14	2.58	3.44	0.86	1.72	1.29	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	95.70	0.00	0.00	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	103.30	5.16	5.16	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	53.59	5.52	1.62	0.65	0.97	1.95	0.97	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	1.45	2.91	0.00	0.00	2.91	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	72.50	3.73	1.07	0.00	2.13	0.53	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	43.34	0.82	0.82	0.82	0.82	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	45.48	3.50	0.78	0.78	1.17	1.17	1.55	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	2.10	2.10	0.00	2.10	6.30	6.30	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	1.99	0.99	0.00	1.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	0.00	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.17	2.96	0.59	0.59	0.59	1.78	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	2.44	1.22	1.22	1.22	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.07	1.27	0.63	0.63	0.00	0.00	1.90	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	38.28	2.76	0.34	0.00	0.69	0.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	0.00	2.15	0.00	2.15	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	0.00	0.00	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	6.89	3.44	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	46.04	3.26	0.41	0.00	0.81	0.81	1.22	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	43.69	2.38	1.59	0.79	0.79	0.00	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	6.48	0.59	0.59	1.18	1.18	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.52	1.56	0.62	0.31	0.00	0.62	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	44.11	2.67	1.34	0.00	0.00	0.00	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	1.18	2.37	1.18	0.00	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	0.00	5.14	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	2.07	0.69	0.69	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	0.49	0.49	0.00	0.00	0.49	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	0.00	0.00	0.00	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	16.54	0.64	0.00	0.00	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.94	1.61	0.00	1.21	0.00	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	4.36	2.18	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	3.03	1.82	0.61	0.61	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	25.53	2.47	1.65	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.54	2.78	0.00	0.79	0.00	0.00	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	36.67	2.27	0.32	0.65	0.65	0.32	0.32	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	48.89	3.06	2.04	0.00	0.00	0.00	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	208.90	3.87	0.00	2.32	0.77	0.00	0.77	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	153.32	17.48	0.94	0.24	0.71	1.18	0.94	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	162.40	7.88	2.09	1.16	0.70	0.93	0.46	0.23	10.19
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	17.09	4.27	4.27	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.91	1.44	1.54	0.72	0.41	0.92	0.10	0.51	0.21
mesothelioma cell line:Mero-25	10850-111F4	578.73	20.88	25.42	1.13	8.85	11.57	11.35	9.31	0.68
mesothelioma cell line:Mero-41	10851-111F5	125.17	7.09	6.11	1.96	2.69	2.69	2.20	2.20	0.00
mesothelioma cell line:Mero-48a	10852-111F6	50.26	1.99	1.77	0.22	0.44	1.11	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	253.87	10.25	8.41	0.53	2.37	4.99	2.10	4.20	0.00
mesothelioma cell line:Mero-83	10854-111F8	26.55	1.19	1.87	1.02	1.19	0.51	0.51	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	53.08	2.27	2.02	0.51	0.25	0.51	0.25	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	61.91	3.52	3.11	0.41	1.45	1.24	0.83	0.62	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	70.90	5.80	3.64	3.64	0.99	1.33	0.83	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	58.82	3.08	2.71	0.90	0.54	1.45	0.90	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	48.68	7.17	2.39	0.51	1.20	0.85	0.34	1.37	0.51
mesothelioma cell line:NCI-H28	10845-111E8	58.53	4.83	3.82	2.04	0.76	1.02	2.04	1.27	0.25
mesothelioma cell line:No36	10857-111G2	33.27	3.59	0.65	0.98	0.33	0.33	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	68.55	2.98	2.44	0.27	0.27	1.35	0.81	1.90	0.00
migratory langerhans cells, donor1	11901-125F2	2.69	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	1.47	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	2.51	0.18	0.00	0.00	0.18	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.42	4.90	3.26	0.33	1.31	1.63	4.90	2.61	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.29	4.45	0.64	0.42	0.21	0.42	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	167.70	10.14	0.23	0.00	0.23	0.69	0.92	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	64.86	9.42	1.85	0.18	0.55	0.37	0.37	0.37	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	53.77	5.07	0.51	0.00	0.00	0.00	0.00	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	59.17	3.45	1.56	0.56	0.45	0.45	0.45	0.89	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.54	3.60	0.81	0.29	0.51	0.44	0.51	0.44	0.00
nasal epithelial cells, donor2	12227-129F4	71.76	3.86	0.55	1.10	1.10	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1.61	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	0.56	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.16	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.60	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	158.37	8.25	1.33	0.80	0.53	0.27	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	63.16	8.34	1.28	1.60	2.24	0.96	0.32	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.94	4.47	2.10	0.26	1.31	2.63	2.36	3.15	0.00
nucleus accumbens, adult, pool1	10037-101F1	112.02	2.44	1.50	1.59	0.37	0.56	0.37	0.19	4.69
occipital cortex - adult, donor10196	10172-103C1	74.17	4.12	4.12	0.00	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	113.79	2.68	1.61	0.54	1.07	2.15	0.81	0.81	3.22
occipital cortex, newborn, donor10223	10355-105E4	18.20	0.36	0.00	0.73	0.00	0.36	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	92.63	1.05	1.31	1.31	1.57	0.52	0.79	0.52	2.36
occipital lobe, fetal, donor1	10073-102A1	15.45	2.15	0.86	0.43	0.00	0.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	117.24	2.60	1.73	0.95	0.16	0.55	0.16	0.16	4.18
olfactory region, adult	10195-103E6	70.88	0.96	3.82	3.44	1.34	2.67	0.57	0.76	2.48
optic nerve, donor1	10277-104E7	436.23	8.00	6.00	4.00	6.00	12.01	2.00	2.00	16.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	53.65	2.05	1.25	0.91	1.37	0.68	0.46	0.46	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.28	4.67	0.55	0.96	0.41	0.27	0.00	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.26	1.19	1.35	0.17	0.68	1.19	0.51	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	160.33	14.79	3.58	0.58	1.73	3.12	2.43	2.19	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	201.96	12.93	1.47	4.70	3.82	1.18	1.76	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	142.95	8.41	0.00	3.74	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	205.49	4.88	1.48	0.64	2.76	1.48	1.06	1.48	0.00
ovary, adult, pool1	10020-101D2	150.51	13.45	5.15	6.64	5.15	1.05	0.87	2.53	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.98	0.92	0.00	0.37	0.00	0.00	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	304.77	8.47	15.99	4.70	1.88	2.82	2.82	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	74.08	1.96	2.24	0.84	0.84	0.56	0.56	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	72.57	2.38	3.41	0.85	0.85	1.19	1.87	1.02	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	125.01	6.62	2.65	0.00	0.99	0.33	0.66	0.99	0.83
paracentral gyrus, adult, pool1	10035-101E8	111.47	1.83	2.38	2.29	0.37	0.55	0.37	0.09	3.11
parietal cortex, adult, donor10258	10373-105G4	52.11	0.00	0.73	0.73	0.00	0.00	0.00	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	89.35	1.88	5.64	0.00	0.94	0.94	1.88	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	64.99	1.71	2.57	0.86	0.57	0.86	0.00	1.14	2.00
parietal lobe, adult, pool1	10034-101E7	131.74	2.29	1.32	1.85	0.62	0.70	0.18	0.26	5.11
parietal lobe, fetal, donor1	10072-101I9	13.58	0.97	0.00	0.97	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.46	0.75	0.37	0.37	0.00	0.00	0.00	0.37	0.00
parotid gland, adult	10199-103F1	84.48	1.85	8.63	1.23	1.85	3.70	0.62	0.00	0.62
penis, adult	10200-103F2	37.60	8.59	2.15	0.54	1.07	1.61	2.69	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.56	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	47.64	5.39	0.87	0.15	0.58	0.44	0.15	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	16.77	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	14.21	1.78	0.00	0.00	0.00	1.18	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	10.66	1.25	0.00	0.63	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	1.01	1.01	1.01	1.01	0.00	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	31.79	1.56	1.04	0.52	0.00	0.52	0.00	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	4.26	1.70	0.85	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	122.45	4.09	3.33	3.23	1.83	1.18	0.22	0.54	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	1.06	0.26	0.00	0.00	0.13	0.00	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	99.76	4.98	0.93	0.62	0.62	0.62	1.40	0.31	0.62
pons, adult, pool1	10033-101E6	147.52	3.44	1.29	1.12	0.52	0.60	0.60	0.34	4.99
postcentral gyrus, adult, pool1	10032-101E5	115.68	2.53	2.35	1.66	0.44	0.87	0.17	0.35	4.79
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	37.00	7.57	0.87	0.87	0.73	1.02	0.29	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	82.58	7.80	1.09	0.18	0.18	0.36	0.18	0.91	0.18
prostate, adult, pool1	10022-101D4	50.88	4.90	1.27	1.63	0.82	0.36	0.27	0.54	0.09
putamen, adult, donor10196	10176-103C5	49.81	1.65	1.89	0.94	0.71	0.71	0.24	0.47	0.94
putamen, adult, donor10252	10152-102I8	50.98	1.96	0.00	1.96	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	3.28	0.00	0.00	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	38.17	2.17	1.93	1.21	0.48	0.24	0.48	0.72	0.72
putamen, newborn, donor10223	10365-105F5	11.99	0.75	0.75	0.00	1.50	0.00	0.00	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	151.58	8.44	0.29	1.75	0.87	0.00	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	107.11	9.74	1.39	0.00	2.78	1.39	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	104.09	7.63	2.76	0.85	0.85	0.85	2.33	1.70	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.05	2.90	0.83	0.83	0.00	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	78.72	6.86	1.99	2.78	0.40	0.40	0.40	0.40	0.10
retinoblastoma cell line:Y79	10475-106I7	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	37.25	5.04	0.12	0.61	0.25	0.00	0.00	0.37	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	356.00	25.59	1.69	1.12	0.56	1.69	1.41	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	77.30	7.58	0.00	0.76	0.00	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	29.30	2.91	1.13	0.00	1.29	0.32	0.49	0.81	0.00
salivary acinar cells, donor2	11772-123I8	48.60	2.07	2.07	0.55	2.34	2.07	0.69	1.24	0.14
salivary acinar cells, donor3	11773-123I9	86.07	1.99	0.00	0.00	1.99	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	121.25	0.00	1.72	0.57	0.00	2.29	1.14	1.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.87	4.55	0.67	0.67	0.51	0.34	0.25	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.92	2.82	0.82	0.59	0.12	0.24	0.12	0.35	0.00
seminal vesicle, adult	10201-103F3	63.49	6.35	2.65	1.59	2.65	0.00	0.53	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	52.96	1.70	1.94	0.00	0.49	1.46	0.97	1.94	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	2.69	0.13	0.27	0.00	0.00	0.00	0.00	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	119.81	6.08	1.44	0.33	0.88	1.11	0.66	0.77	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	169.28	4.00	1.94	0.77	1.94	1.68	0.90	0.52	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	8.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	28.07	3.48	0.60	1.44	1.80	0.12	0.12	0.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	85.43	15.08	4.02	1.01	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	31.56	4.42	0.63	0.63	0.00	0.63	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	7.88	0.95	0.32	0.00	0.32	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.41	5.01	0.77	0.39	0.58	0.19	0.77	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	44.17	1.81	0.82	0.00	0.16	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.16	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	1.31	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	61.39	8.12	0.72	4.66	2.15	0.60	0.24	0.24	0.00
small intestine, fetal, donor1	10064-101I1	56.02	6.63	2.70	0.25	0.98	2.70	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	25.33	2.84	1.29	2.84	0.26	0.00	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	30.02	2.41	0.00	0.00	0.00	0.27	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	193.39	7.57	6.19	0.69	1.84	2.06	3.67	1.61	3.44
spinal cord, adult, donor10252	10159-103A6	140.75	4.73	1.97	0.39	0.39	2.37	1.58	1.58	6.70
spinal cord, adult, donor10258	10369-105F9	44.97	1.38	4.15	1.38	0.69	1.38	2.08	0.69	4.15
spinal cord, fetal, donor1	10056-101H2	128.07	9.76	5.49	2.44	0.00	1.22	0.61	1.22	3.05
spinal cord, newborn, donor10223	10359-105E8	47.30	1.84	0.92	2.30	0.92	0.92	2.30	0.92	5.05
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	155.78	14.79	2.24	3.88	0.30	0.90	1.05	0.30	0.00
spleen, adult, pool1	10025-101D7	35.13	2.97	1.10	0.66	0.88	0.55	0.44	0.11	0.00
spleen, fetal, pool1	10044-101F8	80.33	6.59	1.91	1.67	0.56	0.79	0.32	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	114.12	8.73	0.57	0.57	0.57	0.57	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	105.53	3.84	8.39	0.00	3.15	5.59	4.19	2.80	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	105.94	5.86	1.17	1.56	0.39	0.39	1.56	1.56	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	25.89	3.71	0.34	0.90	0.34	0.34	0.00	0.23	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	49.99	2.54	2.12	0.00	0.42	1.69	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	92.23	8.88	0.85	1.27	0.00	1.27	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	265.93	14.95	1.07	2.14	0.00	1.07	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	119.63	1.14	4.56	0.00	1.14	2.85	2.28	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	379.92	0.00	0.00	0.00	0.00	54.27	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	273.76	4.78	7.89	0.83	3.12	4.98	2.28	1.87	8.52
substantia nigra, adult, donor10258	10371-105G2	52.76	0.52	1.03	1.03	1.03	0.52	0.52	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	83.38	0.00	2.12	0.71	0.00	0.71	0.71	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	47.46	6.19	0.23	0.69	0.46	0.23	0.23	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	143.86	3.65	2.12	2.54	1.02	0.85	0.34	0.17	5.09
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.11	3.56	0.71	0.71	0.71	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.94	1.76	0.00	0.44	0.00	0.44	0.88	0.00	0.00
tenocyte, donor1	11763-123H8	75.06	3.84	3.84	5.24	1.40	2.79	4.19	2.09	0.00
tenocyte, donor2	11765-123I1	79.73	3.05	3.43	3.05	0.76	1.91	0.76	1.91	0.00
tenocyte, donor3	11768-123I4	68.57	3.34	4.45	1.48	0.37	1.48	1.48	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	15.64	2.04	0.17	0.34	0.00	0.17	0.17	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	16.96	2.93	0.62	0.77	0.62	0.15	0.00	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	22.78	3.10	0.46	0.46	0.15	0.31	0.00	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.41	0.51	0.38	0.38	0.13	0.25	0.13	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	0.38	0.38	0.00	0.00	0.38	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3.93	0.33	0.00	0.00	0.00	0.00	0.00	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.61	0.00	0.00	0.00	0.00	0.33	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	72.69	9.77	1.72	0.97	4.62	0.54	0.75	2.36	1.18
testis, adult, pool2	10096-102C6	42.85	3.61	2.26	2.71	1.35	2.26	0.00	2.26	0.00
thalamus - adult, donor10196	10168-103B6	219.69	5.52	4.42	0.00	6.62	0.00	0.00	2.21	5.52
thalamus, adult, donor10252	10154-103A1	239.11	4.84	5.94	1.09	2.50	6.88	1.41	1.25	8.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	55.43	0.00	0.00	0.00	0.00	1.54	1.54	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	87.78	1.48	2.31	0.33	0.33	1.48	1.15	1.81	2.14
thalamus, newborn, donor10223	10366-105F6	12.66	0.00	1.15	0.00	0.00	0.00	0.58	0.58	0.00
throat, adult	10209-103G2	55.68	3.00	1.75	1.50	1.00	2.00	1.00	1.00	0.00
throat, fetal, donor1	10061-101H7	48.45	5.48	2.44	0.61	0.61	0.91	0.00	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	62.00	7.35	1.99	0.20	0.60	0.79	1.19	0.60	0.79
thymus, adult, pool1	10027-101D9	5.27	0.89	0.00	0.00	0.20	0.10	0.00	0.10	0.00
thymus, fetal, pool1	10043-101F7	14.34	1.87	0.42	0.21	0.42	0.42	0.00	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	61.96	4.92	3.46	0.53	1.20	0.53	1.06	0.93	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	81.44	12.71	1.68	2.79	0.84	0.70	0.28	1.12	0.00
thyroid, adult, pool1	10028-101E1	43.20	5.13	1.21	1.49	1.49	0.19	0.19	0.37	0.00
thyroid, fetal, donor1	10060-101H6	36.91	5.27	1.05	0.79	0.53	0.26	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	0.00	0.00	0.00	6.16	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	67.21	3.26	6.05	0.70	4.19	2.33	1.63	1.16	0.23
tongue, fetal, donor1	10059-101H5	63.45	5.12	2.76	1.18	0.39	0.00	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	93.46	3.81	1.30	1.50	0.50	0.30	0.50	0.20	0.30
trachea, adult, pool1	10029-101E2	89.24	5.32	1.47	2.04	1.64	0.57	0.41	0.82	0.65
trachea, fetal, donor1	10058-101H4	51.16	6.92	0.77	0.77	1.54	1.15	0.38	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	78.29	6.02	1.77	0.71	0.35	0.71	0.71	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	65.25	5.17	0.51	3.04	0.51	0.71	0.41	0.41	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.01	10.65	1.10	0.94	2.04	0.31	0.63	0.94	0.00
tridermal teratoma cell line:HGRT	10694-109G1	66.59	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	59.09	3.81	1.27	0.42	0.51	0.59	0.59	0.25	0.00
umbilical cord, fetal, donor1	10057-101H3	58.42	4.17	2.09	4.17	4.17	6.26	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	91.97	7.00	2.39	2.39	0.51	0.85	0.17	0.68	0.68
uterus, fetal, donor1	10055-101H1	78.84	11.26	2.05	0.00	1.54	0.00	0.00	0.51	0.00
vagina, adult	10204-103F6	51.05	4.52	1.29	0.00	1.29	0.65	0.65	1.94	0.00
vein, adult	10191-103E2	46.91	4.38	2.19	0.44	2.41	2.19	0.44	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00